medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Networks of information token recurrences derived from
genomic sequences may reveal hidden patterns in epidemic
outbreaks: A case study of the 2019-nCoV coronavirus.
Markus Luczak-Roesch1*
1 Victoria University of Wellington, School of Information Management
* markus.luczak-roesch@vuw.ac.nz

Abstract
Profiling the genetic evolution and dynamic spreading of viruses is a crucial task when
responding to epidemic outbreaks. We aim to devise novel ways to model, visualise and
analyse the temporal dynamics of epidemic outbreaks in order to help researchers and
other people involved in crisis response to make well-informed and targeted decisions
about from which geographical locations and time periods more genetic samples may be
required to fully understand the outbreak. Our approach relies on the application of
Transcendental Information Cascades to a set of temporally ordered nucleotide sequences,
and we apply it to real-world data that was collected during the currently ongoing
outbreak of the novel 2019-nCoV coronavirus. We assess information-theoretic and
network-theoretic measures that characterise the resulting complex network and identify
touching points and temporal pathways that are candidates for deeper investigation by
geneticists and epidemiologists.

Keywords:
epidemic outbreaks, genome analysis, bioinformatics, complex systems,
network analysis, sequential data mining

Introduction
How far a virus will eventually spread at local, regional, national and international
levels is of central concern during an epidemic outbreak due to the severe consequences
large-scale epidemics have on human well-being [5], the stability and coherence of social
systems [11], and the global economy [23]. A thorough understanding of the genetic
characteristics of a virus is crucial to understand the way it is (or may be) transmitted
(e.g. human-to-human transmissibility) in order to be able to anticipate the potential
reach of an outbreak and develop effective countermeasures. The recent outbreak of a
new type of coronavirus – 2019-nCoV – provides plenty of examples of the way researchers
seek to quickly approach the aforementioned problems of genetic decomposition of the
virus [2, 8] and modelling of its transmission dynamics [15].
Here we present a novel approach to gain insights into the transmission dynamics of an
epidemic outbreak. Our method is based on Transcendental Information Cascades [16,17]
and combines gene sequence analysis with temporal data mining to uncover potential
relationships between a virus’ genetic evolution and distinct occurrences of infections. We
apply this new approach to publicly available genomic sequence data from the currently
ongoing outbreak of the 2019-nCoV coronavirus.

1/33
NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Our results show pathways of similarity between certain clusters of 2019-nCoV virus
samples taken in different geographical locations, and indicate coronavirus cases that
are candidates for further investigation into the human touch points of these patients in
order to derive a detailed understanding of how the virus may have spread, and how and
why it has genetically evolved. Our analysis provides a unique view to the dynamics of
the 2019-nCoV coronavirus outbreak that complements knowledge obtained using other
state-of-the-art methods such as Bayesian evolutionary analysis [9].

Materials and methods
Research data and preprocessing
We obtained a total of 87 genomic sequences from human subjects that were available
via the GISAID EpiFlu Database™ 1 as of Monday, February 10th 2020.
These data were preprocessed using the R programming language. First, we derived
a metadata object that allows to store the sequence identifier, the collection location,
the collection date, and the raw nucleotide sequence. The metadata object was then
filtered to keep only those sequences for which the collection date was not empty and
which featured a length that fell within a margin of 1, 000 of the estimated 30, 000
nucleotides that are currently assumed to make up the genomic code of the 2019-nCoV
coronavirus (i.e. we cover the range of nucleotide sequences from 29, 000 to 31, 000
in length). This left us with a total of 82 genomic sequences. We then exported a
single CSV file containing only the raw nucleotide sequences in ascending order by
the collection date of the sample. This structure is the standard input format for the
genes-CODON-samplesequence tokeniser featured in the Transcendental Information
Cascades R toolchain that is available as free and open scientific software2 .

Construction of Transcendental Information Cascades
Transcendental Information Cascades (TICs) are a method that first transforms any kind
of sequential data into a network of recurring information tokens, to then exploit this
network as a kind of analytical middle ground between views to the source data that would
otherwise only be accessible individually through distinct analytical frameworks [16, 17].
The approach falls into the category of contemporary approaches that make use of
network theory for the study of dynamical complex systems [4, 19, 21]. In the field of
phylogenetic and phylogeographic analysis our approach can be compared to haplotype
networks for example [1, 18] but with the benefit that the resulting network preserves
access to temporal patterns at both macroscopic (e.g. whole generation time periods)
and microscopic (e.g. short time period bursts) resolution.
At an abstract level a Transcendental Information Cascade is constructed from some
sequentially ordered source data in the followFigure 1. Example of the
ing way: At first the data from each distinct
unique codon tokenisation
sequence step is processed to extract unique
used in this study. The exinformation tokens. These tokens form the
ample sequence comprises three
identifier set for that particular sequence step.
window steps and shows how the
Then a directed network is generated with one
+1 (marked in blue), +2 (marked
vertex for each sequence step and edges bein orange) and +3 (marked in
tween any two vertices that have a particular
black) reading frames lead to
token from their identifier set in common and
seven unique codon tokens extracted from the nucleotide se- that does not occur in any identifier set of vertices that represent sequence steps between
quence.
1 https://www.gisaid.org/
2 https://github.com/vuw-c2lab/transcendental-information-cascades

2/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

these two. In other words, identifier sets represent information token co-occurrences and
edges represent information token recurrences.
As the information tokens of interest in this study we encode unique codon identifiers
as (a) their position when sliding a window of size 3 in steps of size 3 over the nucleotide
sequence (e.g. ”pos1”, ”pos2”, ...), (b) a flag that indicates the reading frame (”+1”,
”+2” or ”+3”) that captures the respective triplet in the current window, and (c)
the actual matched nucleotide triplet that constitutes the matched codon. The use
of this tokenisation is motivated by previous work on phylogenetic profiling and gene
sequencing [6, 13] that suggested that codons suit well for assessing similarities (and
dissimilarities) at the gene, chromosome, or genome levels [6, 14, 22].
An example of the particular encoding we use is visualised in Figure 1. It is this
tokenisation of the original nucleotide sequences that we use in the TIC approach to
construct the information token recurrence network from. This means in our TIC
instantiation the nodes represent distinct nucleotide sequences of the virus obtained
from patient samples ordered by the date of their collection by researchers (random
order in case of same date collections). The edges are unique codon identifier recurrences
matched between different nucleotide sequences.

Analysis of Transcendental Information Cascades
The TIC network we derive in the way described before can be analysed in a variety of
ways. Information-theoretic and network-theoretic measures have been introduced as the
base framework to start the analysis from [16]. In particular we perform (1) an analysis
of the information token entropy and evenness over time, (2) an analysis of network
clusters of sequences that can be detected in the TIC network, and (3) an analysis of
the intra-cluster and inter-cluster nucleotide similarity of the original sequences.
Information token entropy and evenness We perform an analysis of information
token entropy and information token evenness in order to understand whether the virus
evolution can be considered an open or a closed system. Therefore we assess both
measures in an accumulated fashion for each progression step through the ordered
nucleotide sequences. In a closed system the information token entropy should strive
towards an equilibrium of maximum entropy and not feature any wave-like up and
down patterns. If we observe wave-like patterns it means nucleotide sequences at
later progression stages feature codon identifiers that have not been observed in earlier
nucleotide sequences.
So to measure information token entropy we assess which unique codon identifiers
were seen up to a progression step and how often these were seen. This allows to compute
the probability for every codon identifier, which then can be used to determine the
information token entropy up to that point following the definition of Shannon entropy
given as follows:
H0 = −

R
X

pi ln pi

(1)

i=1

Analog to this we can then assess the information token evenness as per Pielou’s
species evenness index, which is defined as
J0 =

H0
0
Hmax

(2)

0
where H 0 is the measured Shannon entropy, and Hmax
is the maximum entropy that
would be measured if all tokens would be equally likely to occur.

3/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Network analysis The Transcendental Information Cascade network we constructed
can be mathematically and visually analysed in order to find structures that are of
particular significance for a single epidemic outbreak or to compare different outbreaks
structurally. In this study we focus on the former due to the lack of comparative data
about other epidemic outbreaks.
We first perform a cluster analysis using the random walk apporach by Blondel et
al. [3] on the weighted network that we can construct from our original TIC network by
collapsing all edges between the same vertices to unique edges weighted by the sum of
the collapsed edges (see Figure 2 for a schematic example and Figure 4 for the actual
networks we construct following this approach). Afterwards, we analyse visually the
network using the open source software Gephi. In Gephi we scale vertices by their degree
and edges by their weight. Furthermore, we colour vertices by their cluster membership.
We then run the Yifan Hu [12] layout algorithm (optimal distance: 10,000; relative
strength: 0.2; initial step size: 20; step ratio: 0.95; quadtree max level: 50; theta: 0.8;
convergence threshold: 1 ∗ 10−4 ; adaptive cooling: enabled) to visualise the network.
We repeat the exact same process to construct and visualise three further networks (cf.
Figures 5-7) that are representative of the TIC when exclusively focusing on the codon
identifiers of each of the reading frames individually.

Figure 2. Schematic example of the weighted TIC network constructed from nucleotide
sequences with tokenised unique codon identifiers.

Cluster evaluation In order to evaluate the meaningfulness of the TIC network
against some baseline, we computer the intra-cluster and inter-cluster similarity of
the raw nucleotide sequences. This is done by computing all pairwise comparisons of
sequences within individual clusters (intra-cluster similarity) and comparison between all
sequences from a cluster with all sequences that are not within that cluster (inter-cluster
similarity) using the compareStrings function provided by the Biostrings R package [20].
The similarity of two sequences is then simply defined as follows:
sim(a, b) = 1 −

number of dif f erent nucleotides
length of compared nucleotide sequence

(3)

It is important to note that not all sequences we obtained had the exact same length
(mean length of nucleotide sequences: 29861.95; standard deviation: 28.40705). Hence,
we performed this comparison only on the sub-sequence from the first nucleotide position
to the maximum nucleotide position of the shorter of the two sequences a and b.

4/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Results and discussion
Information-theoretic analysis
Figure 3 shows the graphs for the information token entropy and information token
evenness. As one can see, these feature
Figure 3.
Informationthe aforementioned wave-like patterns, which
theoretic assessment. Both enmeans the system can be regarded open in
tropy and evenness graphs feature
the sense that over time the number of unique
wave-like patterns, indicating that
codon identifiers grows.
the set of observed unique codon
It is important to note that the evenness of
identifiers grows with increasing
the distribution of codon identifiers is relatively
progression stages while the dishigh, converging around a value of 0.95. This
tribution of all observed unique
means that those codon identifiers that have
codon identifiers remains rather
been observed are quite evenly distributed.
even.
These results allow the interpretation that
(a) there is evolving variation in the genomic
sequences we studied, but (b) there is no indication for the dominance of a particular variance.

Network analysis
The weighted network derived from the original TIC network features a modularity of
0.762 and a diameter of 7, which mainly reflects its small size and its particular structure
that results from preserving temporal order in the sense that edges can only ever direct
forward in time (i.e. to vertices that represent a later stage). However, with an average
degree of 8.671 we find that there is certainly structure that differs from just simple
step-by-step forward paths that lead to the consecutively next node. This latter result
suggests that some codon paths branch and merge, emphasising that there is an evolving
variation in the studied genomic sequences.
From the cluster analysis in combination with a visual inspection of the resulting
graph (please refer to Figure 6 as well as Table 11 in the appendix) we find the following
patterns that are noteworthy:
• At the center of the network one cluster emerges (dark red, cluster 0) that has
only few stronger connections within the cluster but features connections to all
other clusters and within itself through lower weighted edges. This cluster has
no temporal focus, it comprises samples that were collected early as well as later
during the outbreak. While the genome sequences that represent the beginning
of the progression stage path in this cluster are from China, it then transitions
geographically to Australia, Japan, Korea, Germany, Taiwan and Singapore.
• The light red cluster (cluster 1) comprises a coherent sequence of samples taken
from patients in the original outbreak region (Wuhan) and is temporally focused
on the early progression stages.
• The orange cluster starting from the bottom center of the network (cluster 2) is
again first a sequence of samples from the original outbreak region in Wuhan,
transitioning to Thailand (Nonthaburi), then back to China (Guangdong), before
finishing in France.
• Cluster 3 (yellow) features samples taken in various places in China but also two
later connections to the USA.

5/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

• Cluster 4 (light green) is one of the smallest clusters but is spread fairly wide
temporally. It features 4 samples taken in China and then transitions geographically
to Singapore and France.
• In dark green (cluster 5) we can identify a cluster of genome data that was collected
in Chonggqing, the USA and Singapore.
• The light blue cluster (cluster 6) is a temporally quite coherent sequence that links
samples taken in Guangdong, Guangzhou and Foshan.
• A kind of international cluster (samples from Australia, the USA, England, Finland
and Belgium) is represented by the dark blue cluster (cluster 7).

73 - BetaCoV/Finland/1/2020

1 - BetaCoV/Wuhan/IPBCAMS-WH-01/2019

74 - BetaCoV/USA/CA3/2020
67 - BetaCoV/USA/W A 1-F6/2020
53 - BetaCo V/Foshan/20SF2 10/2020
52 - BetaCo V/Foshan/20SF207/2020

82 - BetaCoV/Belgium/GHB-0302 1/2020

72 - BetaCoV/England/02/2020
76 - BetaCoV/USA/CA5/2020
71 - BetaCoV/England/01/2020
3 - BetaCoV/Wuhan/IV DC-HB-01/2019
77 - BetaCo V/France/IDF05 15/2020

57 - BetaCoV/Guangdong/20SF201/2020

66 - BetaCoV/USA/WA1-A12/2020

54 - BetaCoV/Foshan/20SF21 1/2020

78 - BetaCov/France/IDF0626/2020
69 - BetaCoV/Germany/BavPat 1/2020

12 - BetaCoV/Wuhan/IPBCAMS-WH-03/2019

61 - BetaCoV/Chonggqing/ZX0 1/2020
70 - BetaCoV/Australia/QLD0O1/2020
63 - BetaCoV/Australia/VICO1/2020
68 - BetaCoV/Singapore/2/2020
81 - BetaCoV/Singapore/3/2020
4 - BetaCoV/Wuhan/IV DC-HB-05/2019
56 - BetaCoV/USA/CA1/2020

75 - BetaCoV/USA/CA4/2020

80 - BetaCoV/Taiwan/NTU01/2020

29 - BetaCoV/Guangdong/20SFO0 14/2020
60 - BetaCoV/Singapore/ 1/2020
79 - BetaCoV/Australia/QLD02/2020
64 - BetaCoV/Japan/AI/I-004/2020
51 - BetaCoV/Guangzhou/20SF206/2020
65 - BetaCoV/Korea/KCDC03/2020
59 - BetaCoV/France/IDF0373/2020

5 - BetaCoV/Wuhan/WIV04/2019

2 - BetaCov/Wuhan/WHO01/2019

55 - BetaCoV/Taiwan/2/2020

58 - BetaCo V/France/IDF0372/2020
34 - BetaCoV/Shenzhen/SZTH-004/2020
48 - BetaCoV/USA/CA2/2020
62 - BetaCoV/Australia/NS WO 1/2020

14 - BetaCoV/Wuhan/IV DC-HB-04/2020

19 - BetaCov/Wuhan/WH04/2020
7 - BetaCoV/Wuhan/WIV05/2019

9 - BetaCoV/Wuhan/WIV07/2019
32 - BetaCoV/Zhejiang/WZ-0 1/2020
36 - BetaCoV/Zhejiang/WZ-02/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
35 - BetaCoV/Guangdong/20SF028/2020

50 - BetaCoV/Guangdong/20SF174/2020
8 - BetaCoV/Wuhan/WIV06/2019
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
6 - BetaCoV/Wuhan/WIV02/2019

30 - BetaCoV/Guangdong/20SF025/2020

11 - BetaCoV/Wuhan/IPBCAMS-WH-04/2019
42 - BetaCoV/Hangzhou/HZCDC000
1/2020
47 - BetaCoV/Chonggqing/Y
C0 1/2020
16 - BetaCov/Wuhan/WH03/2020

13 - BetaCoV/Wuhan/IPBCAMS-WH-02/2019

31 - BetaCoV/Sichuan/ITVDC-SC-00 1/2020
44 - BetaCoV/Jiangsu/IVDC-JS-00 1/2020
38DC-BJ-005/2020
- BetaCoV/Guangdong/20SF040/2020
40 - BetaCoV/Beijing/IV
49 - BetaCoV/USA/AZ1/2020
24 - BetaCoV/Nonthaburi/74/2020
10 - BetaCoV/Wuhan/HBCDC-HB-01/2019

22 - BetaCoV/Shenzhen/HKU-SZ-005/2020
25 - BetaCoV/Shenzhen/SZTH-00 1/2020

18 - BetaCoV/China/WHU02/2020
43 - BetaCoV/Shandong/IVDC-SD-00 1/2020

15 - BetaCoV/Wuhan/IPBCAMS-WH-05/2020
17 - BetaCoV/China/WHU01/2020

37 - BetaCoV/Yunnan/IVDC- Y N-003/2020

20 - BetaCoV/Nonthaburi/6 1/2020
28 - BetaCoV/Guangdong/20SFO0 13/2020

46 - BetaCoV/USA/IL 1/2020

23 - BetaCoV/Jiangxi/IV DC-JX-002/2020

41 - BetaCoV/USA/WA 1/2020

26 - BetaCoV/Shenzhen/SZTH-002/2020

39 - BetaCoV/Chongqing/IVDC-CQ-00 1/2020

27 - BetaCoV/Guangdong/20SFO0 12/2020

Figure 4. Figure 4. Weighted TIC network. From the original TIC network
we generate a weighted network by collapsing all edges between the same vertices to
unique edges weighted by the sum of the collapsed edges. The colours represent the
nine identified network clusters. Node size represents the degree and edge thickness
represents edge weight (in the sense that higher edge weight indicates a higher amount of
codon identifiers shared by two vertices). Numeric indices before the genome identifiers
represent the progression stage index of the particular vertex in the sequence of all
ordered nucleotide sequences we analysed.
We suggest that while there are some obvious pathways of high similarity due to
temporal order of the samples taken, there are still good indications for geographicaldependencies and transition phases that deserve further investigation. Transition points
into and out of cluster 0 are particularly interesting in this regard, especially when the
clusters linking in our out feature samples taken outside of China. We suggest that it

6/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

may be worth to qualitatively assess the human-to-human connections the respective
subjects had from which these samples were taken, and the places they have visited if
there are no known links between the samples so far.
Triangulating the full TIC network with the networks that focus on individual reading
frame similarity only (please refer to Figures 6, 7 and 8 as well as Tables 13, 15 and 17
in the appendix) shows that the macroscopic structure is mostly consistent but much
sparser in terms of low-weighted edges.

Inter- and intra-cluster similarity
From our measurement of the intra-cluster similarity (see Table 1) we find that the
genomic similarity at the level of nucleotides is low in the central cluster 0, which is
expected because this is the largest of all clusters with low temporal coherence. However,
cluster 5 also features a slightly lower average similarity with comparably high standard
deviation, which indicates that this cluster may be slightly less coherent.
Table 1. Intra-cluster similarities.
Cluster

Avg. similarity

SD

Min. similarity

Max. similarity

Cluster size

0
1
2
3
4
5
6
7

0.277353
0.999730
0.999915
0.999385
0.998768
0.883701
0.999926
0.997900

0.088247
0.000222
0.000048
0.000371
0.001345
0.112398
0.000036
0.002419

0.250620
0.999231
0.999832
0.998461
0.996387
0.781976
0.999866
0.991158

0.999866
1.000000
1.000000
0.999933
1.000000
0.999899
1.000000
1.000000

24
9
11
10
6
6
6
10

The barchart of the inter-cluster analysis results shown in Figure 5 reveals that there
are some cluster pairs with high inter-cluster similarity, that the inter-cluster similarity
is different between the +3 reading frame network and the other two reading frame
networks, and that the pattern of the +3 reading frame network inter-cluster similarity
is similar to the one for the entire TIC network. In particular we find that in the +1 and
+2 reading frame networks the clusters 1, 4, 6 and 7 are quite similar at the nucleotide
level compared to all other clusters that are pairwise distinct. For the entire TIC network
and the +3 reading frame network instead we find that clusters 1, 3, 5 and 7 show
this kind of similarity. Altogether, these results indicate that (a) in some instances
the clustering based on structural characteristics of the TIC network overrides actual
genomic similarity, and (b) the choice of the reading frames during TIC construction
has an impact on the resulting network that needs to be further investigated.

Conclusion
In this paper we presented a novel way to model, visualise and analyse the temporal
dynamics of an epidemic outbreak. We applied Transcendental Information Cascades
to capture the recurrence and co-occurrence of unique codon identifiers over distinct
and temporally ordered nucleotide sequences derived from genetic samples taken from
different human subjects. Our case study was focused on the recent outbreak of the novel
2019-nCoV coronavirus. We find clusters and evolution pathways of virus genomes in the
constructed Transcendental Information Cascade that are candidates to be investigated
further for potential human-to-human transmission paths and genetic evolution of the
2019-nCoV coronavirus.
Our study was performed as a snapshot case study on a limited sample of virus data.
While this was at the time of this study all data that was available, we will need to
re-execute this analysis continuously as more data becomes available to check whether
any of our results change. Furthermore, our results indicate that experiments with

7/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

(a)

(b)

(c)

(d)

Figure 5. Overview of inter-cluster similarities for (a) the full TIC network, (b) the +1
reading frame network, (c) the +2 reading frame network, and (d) the +3 reading frame
network.

8/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

alternative tokenisations are needed, such as weighting the +1, +2 and +3 reading frames
differently (or omitting certain frames entirely) depending on their functional role [10].
We also suggest that it will be important to perform a wider variety of analysis of the
generated TIC data (e.g. testing of different network clustering methods, application
of dynamical systems analyses techniques) to get more profound insights. Our analysis
also does not take measurement biases into account that may results from different
techniques used by different laboratories for genome extraction and analysis [7].
In summary, the approach presented in this paper is exploratory and hypotheses
generating in nature. It does not confirm or reject any of the hypotheses we generated
about the potential transmission and evolution pathways nor does it provide causal
explanation for the patterns found. However, the purpose of our work is to provide an
alternative view to the epidemic dynamics of the 2019-nCoV outbreak (and potential
other outbreaks in the future) that is hidden to state-of-the-art methods, and that may
trigger geneticists and epidemiologists to look at pathways in epidemic outbreaks they
would not normally be aware of.

References
1. H.-J. Bandelt, P. Forster, and A. Röhl. Median-joining networks for inferring
intraspecific phylogenies. Molecular biology and evolution, 16(1):37–48, 1999.
2. D. Benvenuto, M. Giovannetti, A. Ciccozzi, S. Spoto, S. Angeletti, and M. Ciccozzi.
The 2019-new coronavirus epidemic: evidence for virus evolution. Journal of
Medical Virology, 2020.
3. V. D. Blondel, J.-L. Guillaume, R. Lambiotte, and E. Lefebvre. Fast unfolding
of communities in large networks. Journal of statistical mechanics: theory and
experiment, 2008(10):P10008, 2008.
4. S. Boccaletti, G. Bianconi, R. Criado, C. I. Del Genio, J. Gómez-Gardenes,
M. Romance, I. Sendina-Nadal, Z. Wang, and M. Zanin. The structure and
dynamics of multilayer networks. Physics Reports, 544(1):1–122, 2014.
5. O. Cenciarelli, S. Pietropaoli, A. Malizia, M. Carestia, F. D’Amico, A. Sassolini,
D. Di Giovanni, S. Rea, V. Gabbarini, A. Tamburrini, et al. Ebola virus disease
2013-2014 outbreak in west africa: an analysis of the epidemic spread and response.
International journal of microbiology, 2015, 2015.
6. P. Cliften, P. Sudarsanam, A. Desikan, L. Fulton, B. Fulton, J. Majors, R. Waterston, B. A. Cohen, and M. Johnston. Finding functional features in saccharomyces
genomes by phylogenetic footprinting. science, 301(5629):71–76, 2003.
7. A. S. Devonshire, A. S. Whale, A. Gutteridge, G. Jones, S. Cowen, C. A. Foy, and
J. F. Huggett. Towards standardisation of cell-free dna measurement in plasma:
controls for extraction efficiency, fragment size bias and quantification. Analytical
and bioanalytical chemistry, 406(26):6499–6512, 2014.
8. N. Dong, X. Yang, L. Ye, K. Chen, E. W.-C. Chan, M. Yang, and S. Chen. Genomic
and protein structure modelling analysis depicts the origin and infectivity of 2019ncov, a new coronavirus which caused a pneumonia outbreak in wuhan, china.
bioRxiv, 2020.
9. A. J. Drummond and A. Rambaut. Beast: Bayesian evolutionary analysis by
sampling trees. BMC evolutionary biology, 7(1):214, 2007.

9/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

10. P. J. Farabaugh and G. R. Björk. How translational accuracy influences reading
frame maintenance. The EMBO journal, 18(6):1427–1434, 1999.
11. J. Faulkner, M. Schaller, J. H. Park, and L. A. Duncan. Evolved disease-avoidance
mechanisms and contemporary xenophobic attitudes. Group Processes & Intergroup Relations, 7(4):333–353, 2004.
12. Y. Hu. Efficient, high-quality force-directed graph drawing. Mathematica Journal,
10(1):37–71, 2005.
13. M. Kellis, N. Patterson, M. Endrizzi, B. Birren, and E. S. Lander. Sequencing
and comparison of yeast species to identify genes and regulatory elements. Nature,
423(6937):241, 2003.
14. C. Li, X. Yu, and N. Helal. Similarity analysis of dna sequences based on codon
usage. Chemical physics letters, 459(1-6):172–174, 2008.
15. T. Liu, J. Hu, M. Kang, L. Lin, H. Zhong, J. Xiao, G. He, T. Song, Q. Huang,
Z. Rong, et al. Transmission dynamics of 2019 novel coronavirus (2019-ncov).
bioRxiv, 2020.
16. M. Luczak-Roesch, K. O’Hara, J. D. Dinneen, and R. Tinati. What an entangled
web we weave: An information-centric approach to time-evolving socio-technical
systems. Minds and Machines, 28(4):709–733, 2018.
17. M. Luczak-Roesch, R. Tinati, M. Van Kleek, and N. Shadbolt. From coincidence
to purposeful flow? properties of transcendental information cascades. In 2015
IEEE/ACM International Conference on Advances in Social Networks Analysis
and Mining (ASONAM), pages 633–638. IEEE, 2015.
18. I. Manolopoulou, L. Legarreta, B. C. Emerson, S. Brooks, and S. Tavaré. A
bayesian approach to phylogeographic clustering. Interface focus, 1(6):909–921,
2011.
19. N. Masuda and P. Holme. Detecting sequences of system states in temporal
networks. Scientific reports, 9(1):1–11, 2019.
20. G. R. D. S. Pagès H, Aboyoun P. Biostrings: Efficient manipulation of biological
strings, 2019. R package version 2.54.0.
21. M. A. Porter. Nonlinearity+ networks:
arXiv:1911.03805, 2019.

A 2020 vision.

arXiv preprint

22. P. M. Sharp and W.-H. Li. The codon adaptation index-a measure of directional
synonymous codon usage bias, and its potential applications. Nucleic acids
research, 15(3):1281–1295, 1987.
23. R. D. Smith. Responding to global infectious disease outbreaks: lessons from sars
on the role of risk perception, communication and management. Social science &
medicine, 63(12):3113–3123, 2006.

10/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Appendix
The software developed for this particular analysis is part of the open scientific software
”R toolchain to construct and analyse Transcendental Information Cascades” that is available via https://github.com/vuw-c2lab/transcendental-information-cascades/
tree/master/input/2020-02-03-2019nCoV. For reproduction purposes it is necessary
to obtain the raw genomic data used in this study from the GISAID EpiFlu Database™.
For further reference we provide the raw results of some of our analysis. We particularly point to the tables that provide references for relationships between nucleotide
sequences and the cluster membership of nucleotide sequences.

11/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Table 2. Edge weight between distinct nucleotide sequences in the Transcendental
Information Cascade we constructed.
Source sequence

Target sequence

Edge weight

11 - BetaCoV/Wuhan/IPBCAMS-WH-04/2019
3 - BetaCoV/Wuhan/IV DC-HB-01/2019
4 - BetaCoV/Wuhan/IV DC-HB-05/2019
66 - BetaCoV/USA/WA1-A12/2020
74 - BetaCoV/USA/CA3/2020
17 - BetaCoV/China/WHU01/2020
14 - BetaCoV/Wuhan/IV DC-HB-04/2020
12 - BetaCoV/Wuhan/IPBCAMS-WH-03/2019
13 - BetaCoV/Wuhan/IPBCAMS-WH-02/2019
75 - BetaCoV/USA/CA4/2020
48 - BetaCoV/USA/CA2/2020
22 - BetaCoV/Shenzhen/HKU-SZ-005/2020
27 - BetaCoV/Guangdong/20SFO0 12/2020
28 - BetaCoV/Guangdong/20SFO0 13/2020
29 - BetaCoV/Guangdong/20SFO0 14/2020
71 - BetaCoV/England/01/2020
52 - BetaCo V/Foshan/20SF207/2020
51 - BetaCoV/Guangzhou/20SF206/2020
25 - BetaCoV/Shenzhen/SZTH-00 1/2020
53 - BetaCo V/Foshan/20SF2 10/2020
50 - BetaCoV/Guangdong/20SF174/2020
73 - BetaCoV/Finland/1/2020
72 - BetaCoV/England/02/2020
1 - BetaCoV/Wuhan/IPBCAMS-WH-01/2019
37 - BetaCoV/Yunnan/IVDC- Y N-003/2020
26 - BetaCoV/Shenzhen/SZTH-002/2020
24 - BetaCoV/Nonthaburi/74/2020
39 - BetaCoV/Chongqing/IVDC-CQ-00 1/2020
23 - BetaCoV/Jiangxi/IV DC-JX-002/2020
41 - BetaCoV/USA/WA 1/2020
54 - BetaCoV/Foshan/20SF21 1/2020
49 - BetaCoV/USA/AZ1/2020
40 - BetaCoV/Beijing/IV DC-BJ-005/2020
20 - BetaCoV/Nonthaburi/6 1/2020
63 - BetaCoV/Australia/VICO1/2020
35 - BetaCoV/Guangdong/20SF028/2020
43 - BetaCoV/Shandong/IVDC-SD-00 1/2020
56 - BetaCoV/USA/CA1/2020
65 - BetaCoV/Korea/KCDC03/2020
68 - BetaCoV/Singapore/2/2020
30 - BetaCoV/Guangdong/20SF025/2020
67 - BetaCoV/USA/W A 1-F6/2020
31 - BetaCoV/Sichuan/ITVDC-SC-00 1/2020
10 - BetaCoV/Wuhan/HBCDC-HB-01/2019
62 - BetaCoV/Australia/NS WO 1/2020
76 - BetaCoV/USA/CA5/2020
15 - BetaCoV/Wuhan/IPBCAMS-WH-05/2020
5 - BetaCoV/Wuhan/WIV04/2019
38 - BetaCoV/Guangdong/20SF040/2020
58 - BetaCo V/France/IDF0372/2020
18 - BetaCoV/China/WHU02/2020
32 - BetaCoV/Zhejiang/WZ-0 1/2020
44 - BetaCoV/Jiangsu/IVDC-JS-00 1/2020
60 - BetaCoV/Singapore/ 1/2020
47 - BetaCoV/Chonggqing/Y C0 1/2020
46 - BetaCoV/USA/IL 1/2020
61 - BetaCoV/Chonggqing/ZX0 1/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
46 - BetaCoV/USA/IL 1/2020
60 - BetaCoV/Singapore/ 1/2020
47 - BetaCoV/Chonggqing/Y C0 1/2020
55 - BetaCoV/Taiwan/2/2020
55 - BetaCoV/Taiwan/2/2020
44 - BetaCoV/Jiangsu/IVDC-JS-00 1/2020
55 - BetaCoV/Taiwan/2/2020
5 - BetaCoV/Wuhan/WIV04/2019
62 - BetaCoV/Australia/NS WO 1/2020
69 - BetaCoV/Germany/BavPat 1/2020
67 - BetaCoV/USA/W A 1-F6/2020
10 - BetaCoV/Wuhan/HBCDC-HB-01/2019
16 - BetaCov/Wuhan/WH03/2020
78 - BetaCov/France/IDF0626/2020
61 - BetaCoV/Chonggqing/ZX0 1/2020
59 - BetaCoV/France/IDF0373/2020
6 - BetaCoV/Wuhan/WIV02/2019
35 - BetaCoV/Guangdong/20SF028/2020
36 - BetaCoV/Zhejiang/WZ-02/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
78 - BetaCov/France/IDF0626/2020
8 - BetaCoV/Wuhan/WIV06/2019

12 - BetaCoV/Wuhan/IPBCAMS-WH-03/2019
4 - BetaCoV/Wuhan/IV DC-HB-05/2019
5 - BetaCoV/Wuhan/WIV04/2019
67 - BetaCoV/USA/W A 1-F6/2020
75 - BetaCoV/USA/CA4/2020
18 - BetaCoV/China/WHU02/2020
15 - BetaCoV/Wuhan/IPBCAMS-WH-05/2020
13 - BetaCoV/Wuhan/IPBCAMS-WH-02/2019
14 - BetaCoV/Wuhan/IV DC-HB-04/2020
76 - BetaCoV/USA/CA5/2020
49 - BetaCoV/USA/AZ1/2020
23 - BetaCoV/Jiangxi/IV DC-JX-002/2020
28 - BetaCoV/Guangdong/20SFO0 13/2020
29 - BetaCoV/Guangdong/20SFO0 14/2020
30 - BetaCoV/Guangdong/20SF025/2020
72 - BetaCoV/England/02/2020
53 - BetaCo V/Foshan/20SF2 10/2020
52 - BetaCo V/Foshan/20SF207/2020
26 - BetaCoV/Shenzhen/SZTH-002/2020
54 - BetaCoV/Foshan/20SF21 1/2020
51 - BetaCoV/Guangzhou/20SF206/2020
74 - BetaCoV/USA/CA3/2020
73 - BetaCoV/Finland/1/2020
3 - BetaCoV/Wuhan/IV DC-HB-01/2019
39 - BetaCoV/Chongqing/IVDC-CQ-00 1/2020
31 - BetaCoV/Sichuan/ITVDC-SC-00 1/2020
27 - BetaCoV/Guangdong/20SFO0 12/2020
41 - BetaCoV/USA/WA 1/2020
25 - BetaCoV/Shenzhen/SZTH-00 1/2020
43 - BetaCoV/Shandong/IVDC-SD-00 1/2020
57 - BetaCoV/Guangdong/20SF201/2020
56 - BetaCoV/USA/CA1/2020
44 - BetaCoV/Jiangsu/IVDC-JS-00 1/2020
24 - BetaCoV/Nonthaburi/74/2020
66 - BetaCoV/USA/WA1-A12/2020
38 - BetaCoV/Guangdong/20SF040/2020
46 - BetaCoV/USA/IL 1/2020
60 - BetaCoV/Singapore/ 1/2020
70 - BetaCoV/Australia/QLD0O1/2020
77 - BetaCo V/France/IDF05 15/2020
35 - BetaCoV/Guangdong/20SF028/2020
71 - BetaCoV/England/01/2020
37 - BetaCoV/Yunnan/IVDC- Y N-003/2020
20 - BetaCoV/Nonthaburi/6 1/2020
69 - BetaCoV/Germany/BavPat 1/2020
82 - BetaCoV/Belgium/GHB-0302 1/2020
22 - BetaCoV/Shenzhen/HKU-SZ-005/2020
11 - BetaCoV/Wuhan/IPBCAMS-WH-04/2019
58 - BetaCo V/France/IDF0372/2020
78 - BetaCov/France/IDF0626/2020
40 - BetaCoV/Beijing/IV DC-BJ-005/2020
59 - BetaCoV/France/IDF0373/2020
68 - BetaCoV/Singapore/2/2020
61 - BetaCoV/Chonggqing/ZX0 1/2020
48 - BetaCoV/USA/CA2/2020
47 - BetaCoV/Chonggqing/Y C0 1/2020
63 - BetaCoV/Australia/VICO1/2020
55 - BetaCoV/Taiwan/2/2020
34 - BetaCoV/Shenzhen/SZTH-004/2020
48 - BetaCoV/USA/CA2/2020
63 - BetaCoV/Australia/VICO1/2020
61 - BetaCoV/Chonggqing/ZX0 1/2020
81 - BetaCoV/Singapore/3/2020
68 - BetaCoV/Singapore/2/2020
55 - BetaCoV/Taiwan/2/2020
64 - BetaCoV/Japan/AI/I-004/2020
6 - BetaCoV/Wuhan/WIV02/2019
63 - BetaCoV/Australia/VICO1/2020
71 - BetaCoV/England/01/2020
69 - BetaCoV/Germany/BavPat 1/2020
16 - BetaCov/Wuhan/WH03/2020
20 - BetaCoV/Nonthaburi/6 1/2020
81 - BetaCoV/Singapore/3/2020
62 - BetaCoV/Australia/NS WO 1/2020
65 - BetaCoV/Korea/KCDC03/2020
11 - BetaCoV/Wuhan/IPBCAMS-WH-04/2019
36 - BetaCoV/Zhejiang/WZ-02/2020
38 - BetaCoV/Guangdong/20SF040/2020
46 - BetaCoV/USA/IL 1/2020
80 - BetaCoV/Taiwan/NTU01/2020
10 - BetaCoV/Wuhan/HBCDC-HB-01/2019

29885
29883
29883
29880
29880
29879
29872
29870
29867
29865
29862
29856
29843
29831
29831
29830
29828
29825
29813
29801
29797
29665
29643
29346
29332
29315
29290
29274
29248
29142
28741
28651
28650
28586
28557
28532
28469
28287
28136
28051
27962
27952
27711
27513
27286
27215
27049
26905
26795
26624
25949
25427
22332
21150
21147
21143
20532
20288
20102
8710
8389
7936
4399
3424
3393
904
848
838
826
815
812
806
779
773
773
771
771
767
762
758
755

12/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Table 3. Edge weight between distinct nucleotide sequences in the Transcendental
Information Cascade we constructed (contd.).
Source sequence

Target sequence

Edge weight

43 - BetaCoV/Shandong/IVDC-SD-00 1/2020
19 - BetaCov/Wuhan/WH04/2020
34 - BetaCoV/Shenzhen/SZTH-004/2020
57 - BetaCoV/Guangdong/20SF201/2020
69 - BetaCoV/Germany/BavPat 1/2020
15 - BetaCoV/Wuhan/IPBCAMS-WH-05/2020
20 - BetaCoV/Nonthaburi/6 1/2020
6 - BetaCoV/Wuhan/WIV02/2019
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
80 - BetaCoV/Taiwan/NTU01/2020
9 - BetaCoV/Wuhan/WIV07/2019
5 - BetaCoV/Wuhan/WIV04/2019
7 - BetaCoV/Wuhan/WIV05/2019
76 - BetaCoV/USA/CA5/2020
79 - BetaCoV/Australia/QLD02/2020
7 - BetaCoV/Wuhan/WIV05/2019
41 - BetaCoV/USA/WA 1/2020
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
63 - BetaCoV/Australia/VICO1/2020
38 - BetaCoV/Guangdong/20SF040/2020
68 - BetaCoV/Singapore/2/2020
2 - BetaCov/Wuhan/WHO01/2019
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
55 - BetaCoV/Taiwan/2/2020
36 - BetaCoV/Zhejiang/WZ-02/2020
55 - BetaCoV/Taiwan/2/2020
49 - BetaCoV/USA/AZ1/2020
65 - BetaCoV/Korea/KCDC03/2020
70 - BetaCoV/Australia/QLD0O1/2020
16 - BetaCov/Wuhan/WH03/2020
64 - BetaCoV/Japan/AI/I-004/2020
62 - BetaCoV/Australia/NS WO 1/2020
19 - BetaCov/Wuhan/WH04/2020
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
8 - BetaCoV/Wuhan/WIV06/2019
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
9 - BetaCoV/Wuhan/WIV07/2019
30 - BetaCoV/Guangdong/20SF025/2020
18 - BetaCoV/China/WHU02/2020
64 - BetaCoV/Japan/AI/I-004/2020
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
32 - BetaCoV/Zhejiang/WZ-0 1/2020
34 - BetaCoV/Shenzhen/SZTH-004/2020
7 - BetaCoV/Wuhan/WIV05/2019
64 - BetaCoV/Japan/AI/I-004/2020
19 - BetaCov/Wuhan/WH04/2020
8 - BetaCoV/Wuhan/WIV06/2019
2 - BetaCov/Wuhan/WHO01/2019
43 - BetaCoV/Shandong/IVDC-SD-00 1/2020
57 - BetaCoV/Guangdong/20SF201/2020
16 - BetaCov/Wuhan/WH03/2020
59 - BetaCoV/France/IDF0373/2020
34 - BetaCoV/Shenzhen/SZTH-004/2020
36 - BetaCoV/Zhejiang/WZ-02/2020
16 - BetaCov/Wuhan/WH03/2020
39 - BetaCoV/Chongqing/IVDC-CQ-00 1/2020
16 - BetaCov/Wuhan/WH03/2020
8 - BetaCoV/Wuhan/WIV06/2019
44 - BetaCoV/Jiangsu/IVDC-JS-00 1/2020
40 - BetaCoV/Beijing/IV DC-BJ-005/2020
79 - BetaCoV/Australia/QLD02/2020
64 - BetaCoV/Japan/AI/I-004/2020
6 - BetaCoV/Wuhan/WIV02/2019
8 - BetaCoV/Wuhan/WIV06/2019
9 - BetaCoV/Wuhan/WIV07/2019
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
6 - BetaCoV/Wuhan/WIV02/2019
2 - BetaCov/Wuhan/WHO01/2019
19 - BetaCov/Wuhan/WH04/2020
8 - BetaCoV/Wuhan/WIV06/2019
55 - BetaCoV/Taiwan/2/2020
7 - BetaCoV/Wuhan/WIV05/2019
34 - BetaCoV/Shenzhen/SZTH-004/2020
44 - BetaCoV/Jiangsu/IVDC-JS-00 1/2020
76 - BetaCoV/USA/CA5/2020
8 - BetaCoV/Wuhan/WIV06/2019
67 - BetaCoV/USA/W A 1-F6/2020
19 - BetaCov/Wuhan/WH04/2020
15 - BetaCoV/Wuhan/IPBCAMS-WH-05/2020
57 - BetaCoV/Guangdong/20SF201/2020
19 - BetaCov/Wuhan/WH04/2020
68 - BetaCoV/Singapore/2/2020
70 - BetaCoV/Australia/QLD0O1/2020
44 - BetaCoV/Jiangsu/IVDC-JS-00 1/2020
19 - BetaCov/Wuhan/WH04/2020

45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
22 - BetaCoV/Shenzhen/HKU-SZ-005/2020
36 - BetaCoV/Zhejiang/WZ-02/2020
58 - BetaCo V/France/IDF0372/2020
79 - BetaCoV/Australia/QLD02/2020
19 - BetaCov/Wuhan/WH04/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
7 - BetaCoV/Wuhan/WIV05/2019
24 - BetaCoV/Nonthaburi/74/2020
81 - BetaCoV/Singapore/3/2020
17 - BetaCoV/China/WHU01/2020
7 - BetaCoV/Wuhan/WIV05/2019
19 - BetaCov/Wuhan/WH04/2020
79 - BetaCoV/Australia/QLD02/2020
82 - BetaCoV/Belgium/GHB-0302 1/2020
11 - BetaCoV/Wuhan/IPBCAMS-WH-04/2019
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
43 - BetaCoV/Shandong/IVDC-SD-00 1/2020
64 - BetaCoV/Japan/AI/I-004/2020
50 - BetaCoV/Guangdong/20SF174/2020
70 - BetaCoV/Australia/QLD0O1/2020
9 - BetaCoV/Wuhan/WIV07/2019
33 - BetaCoV/Shenzhen/SZTH-003/2020
50 - BetaCoV/Guangdong/20SF174/2020
56 - BetaCoV/USA/CA1/2020
50 - BetaCoV/Guangdong/20SF174/2020
62 - BetaCoV/Australia/NS WO 1/2020
55 - BetaCoV/Taiwan/2/2020
68 - BetaCoV/Singapore/2/2020
77 - BetaCo V/France/IDF05 15/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
66 - BetaCoV/USA/WA1-A12/2020
64 - BetaCoV/Japan/AI/I-004/2020
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
16 - BetaCov/Wuhan/WH03/2020
36 - BetaCoV/Zhejiang/WZ-02/2020
64 - BetaCoV/Japan/AI/I-004/2020
32 - BetaCoV/Zhejiang/WZ-0 1/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
32 - BetaCoV/Zhejiang/WZ-0 1/2020
69 - BetaCoV/Germany/BavPat 1/2020
62 - BetaCoV/Australia/NS WO 1/2020
40 - BetaCoV/Beijing/IV DC-BJ-005/2020
35 - BetaCoV/Guangdong/20SF028/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
79 - BetaCoV/Australia/QLD02/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
50 - BetaCoV/Guangdong/20SF174/2020
17 - BetaCoV/China/WHU01/2020
44 - BetaCoV/Jiangsu/IVDC-JS-00 1/2020
80 - BetaCoV/Taiwan/NTU01/2020
36 - BetaCoV/Zhejiang/WZ-02/2020
68 - BetaCoV/Singapore/2/2020
40 - BetaCoV/Beijing/IV DC-BJ-005/2020
80 - BetaCoV/Taiwan/NTU01/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
40 - BetaCoV/Beijing/IV DC-BJ-005/2020
50 - BetaCoV/Guangdong/20SF174/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
46 - BetaCoV/USA/IL 1/2020
41 - BetaCoV/USA/WA 1/2020
80 - BetaCoV/Taiwan/NTU01/2020
65 - BetaCoV/Korea/KCDC03/2020
19 - BetaCov/Wuhan/WH04/2020
36 - BetaCoV/Zhejiang/WZ-02/2020
65 - BetaCoV/Korea/KCDC03/2020
79 - BetaCoV/Australia/QLD02/2020
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
32 - BetaCoV/Zhejiang/WZ-0 1/2020
79 - BetaCoV/Australia/QLD02/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
58 - BetaCo V/France/IDF0372/2020
62 - BetaCoV/Australia/NS WO 1/2020
50 - BetaCoV/Guangdong/20SF174/2020
59 - BetaCoV/France/IDF0373/2020
77 - BetaCo V/France/IDF05 15/2020
9 - BetaCoV/Wuhan/WIV07/2019
68 - BetaCoV/Singapore/2/2020
62 - BetaCoV/Australia/NS WO 1/2020
17 - BetaCoV/China/WHU01/2020
81 - BetaCoV/Singapore/3/2020
64 - BetaCoV/Japan/AI/I-004/2020
69 - BetaCoV/Germany/BavPat 1/2020
79 - BetaCoV/Australia/QLD02/2020
50 - BetaCoV/Guangdong/20SF174/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020

754
748
747
742
740
731
727
725
715
714
713
711
703
700
700
698
698
698
694
693
687
686
685
685
685
678
677
676
675
675
674
674
671
666
665
664
654
654
651
646
641
637
630
629
628
625
619
618
616
613
608
607
603
602
598
597
596
595
595
594
592
591
590
588
587
587
587
587
586
585
585
584
584
584
583
581
580
579
579
574
571
570
557
557
556
551
550

13/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Table 4. Edge weight between distinct nucleotide sequences in the Transcendental
Information Cascade we constructed (contd.).
Source sequence

Target sequence

Edge weight

23 - BetaCoV/Jiangxi/IV DC-JX-002/2020
58 - BetaCo V/France/IDF0372/2020
77 - BetaCo V/France/IDF05 15/2020
10 - BetaCoV/Wuhan/HBCDC-HB-01/2019
24 - BetaCoV/Nonthaburi/74/2020
26 - BetaCoV/Shenzhen/SZTH-002/2020
30 - BetaCoV/Guangdong/20SF025/2020
37 - BetaCoV/Yunnan/IVDC- Y N-003/2020
38 - BetaCoV/Guangdong/20SF040/2020
59 - BetaCoV/France/IDF0373/2020
35 - BetaCoV/Guangdong/20SF028/2020
19 - BetaCov/Wuhan/WH04/2020
77 - BetaCo V/France/IDF05 15/2020
6 - BetaCoV/Wuhan/WIV02/2019
7 - BetaCoV/Wuhan/WIV05/2019
2 - BetaCov/Wuhan/WHO01/2019
2 - BetaCov/Wuhan/WHO01/2019
54 - BetaCoV/Foshan/20SF21 1/2020
1 - BetaCoV/Wuhan/IPBCAMS-WH-01/2019
18 - BetaCoV/China/WHU02/2020
68 - BetaCoV/Singapore/2/2020
7 - BetaCoV/Wuhan/WIV05/2019
49 - BetaCoV/USA/AZ1/2020
15 - BetaCoV/Wuhan/IPBCAMS-WH-05/2020
20 - BetaCoV/Nonthaburi/6 1/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
56 - BetaCoV/USA/CA1/2020
30 - BetaCoV/Guangdong/20SF025/2020
2 - BetaCov/Wuhan/WHO01/2019
56 - BetaCoV/USA/CA1/2020
58 - BetaCo V/France/IDF0372/2020
69 - BetaCoV/Germany/BavPat 1/2020
55 - BetaCoV/Taiwan/2/2020
57 - BetaCoV/Guangdong/20SF201/2020
80 - BetaCoV/Taiwan/NTU01/2020
18 - BetaCoV/China/WHU02/2020
70 - BetaCoV/Australia/QLD0O1/2020
76 - BetaCoV/USA/CA5/2020
18 - BetaCoV/China/WHU02/2020
70 - BetaCoV/Australia/QLD0O1/2020
38 - BetaCoV/Guangdong/20SF040/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
54 - BetaCoV/Foshan/20SF21 1/2020
44 - BetaCoV/Jiangsu/IVDC-JS-00 1/2020
34 - BetaCoV/Shenzhen/SZTH-004/2020
32 - BetaCoV/Zhejiang/WZ-0 1/2020
62 - BetaCoV/Australia/NS WO 1/2020
2 - BetaCov/Wuhan/WHO01/2019
31 - BetaCoV/Sichuan/ITVDC-SC-00 1/2020
6 - BetaCoV/Wuhan/WIV02/2019
38 - BetaCoV/Guangdong/20SF040/2020
58 - BetaCo V/France/IDF0372/2020
69 - BetaCoV/Germany/BavPat 1/2020
59 - BetaCoV/France/IDF0373/2020
70 - BetaCoV/Australia/QLD0O1/2020
10 - BetaCoV/Wuhan/HBCDC-HB-01/2019
65 - BetaCoV/Korea/KCDC03/2020
57 - BetaCoV/Guangdong/20SF201/2020
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
40 - BetaCoV/Beijing/IV DC-BJ-005/2020
55 - BetaCoV/Taiwan/2/2020
31 - BetaCoV/Sichuan/ITVDC-SC-00 1/2020
16 - BetaCov/Wuhan/WH03/2020
78 - BetaCov/France/IDF0626/2020
34 - BetaCoV/Shenzhen/SZTH-004/2020
18 - BetaCoV/China/WHU02/2020
7 - BetaCoV/Wuhan/WIV05/2019
16 - BetaCov/Wuhan/WH03/2020
5 - BetaCoV/Wuhan/WIV04/2019
16 - BetaCov/Wuhan/WH03/2020
15 - BetaCoV/Wuhan/IPBCAMS-WH-05/2020
31 - BetaCoV/Sichuan/ITVDC-SC-00 1/2020
59 - BetaCoV/France/IDF0373/2020
76 - BetaCoV/USA/CA5/2020
19 - BetaCov/Wuhan/WH04/2020
32 - BetaCoV/Zhejiang/WZ-0 1/2020
58 - BetaCo V/France/IDF0372/2020
63 - BetaCoV/Australia/VICO1/2020
6 - BetaCoV/Wuhan/WIV02/2019
34 - BetaCoV/Shenzhen/SZTH-004/2020
8 - BetaCoV/Wuhan/WIV06/2019
32 - BetaCoV/Zhejiang/WZ-0 1/2020
36 - BetaCoV/Zhejiang/WZ-02/2020
36 - BetaCoV/Zhejiang/WZ-02/2020
69 - BetaCoV/Germany/BavPat 1/2020
15 - BetaCoV/Wuhan/IPBCAMS-WH-05/2020
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
2 - BetaCov/Wuhan/WHO01/2019
7 - BetaCoV/Wuhan/WIV05/2019
34 - BetaCoV/Shenzhen/SZTH-004/2020
5 - BetaCoV/Wuhan/WIV04/2019
9 - BetaCoV/Wuhan/WIV07/2019
7 - BetaCoV/Wuhan/WIV05/2019
59 - BetaCoV/France/IDF0373/2020
16 - BetaCov/Wuhan/WH03/2020
18 - BetaCoV/China/WHU02/2020
19 - BetaCov/Wuhan/WH04/2020
67 - BetaCoV/USA/W A 1-F6/2020
6 - BetaCoV/Wuhan/WIV02/2019

24 - BetaCoV/Nonthaburi/74/2020
59 - BetaCoV/France/IDF0373/2020
78 - BetaCov/France/IDF0626/2020
11 - BetaCoV/Wuhan/IPBCAMS-WH-04/2019
25 - BetaCoV/Shenzhen/SZTH-00 1/2020
27 - BetaCoV/Guangdong/20SFO0 12/2020
31 - BetaCoV/Sichuan/ITVDC-SC-00 1/2020
38 - BetaCoV/Guangdong/20SF040/2020
39 - BetaCoV/Chongqing/IVDC-CQ-00 1/2020
62 - BetaCoV/Australia/NS WO 1/2020
37 - BetaCoV/Yunnan/IVDC- Y N-003/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
81 - BetaCoV/Singapore/3/2020
10 - BetaCoV/Wuhan/HBCDC-HB-01/2019
64 - BetaCoV/Japan/AI/I-004/2020
65 - BetaCoV/Korea/KCDC03/2020
3 - BetaCoV/Wuhan/IV DC-HB-01/2019
55 - BetaCoV/Taiwan/2/2020
2 - BetaCov/Wuhan/WHO01/2019
20 - BetaCoV/Nonthaburi/6 1/2020
71 - BetaCoV/England/01/2020
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
50 - BetaCoV/Guangdong/20SF174/2020
16 - BetaCov/Wuhan/WH03/2020
22 - BetaCoV/Shenzhen/HKU-SZ-005/2020
22 - BetaCoV/Shenzhen/HKU-SZ-005/2020
57 - BetaCoV/Guangdong/20SF201/2020
32 - BetaCoV/Zhejiang/WZ-0 1/2020
6 - BetaCoV/Wuhan/WIV02/2019
58 - BetaCo V/France/IDF0372/2020
60 - BetaCoV/Singapore/ 1/2020
77 - BetaCo V/France/IDF05 15/2020
57 - BetaCoV/Guangdong/20SF201/2020
68 - BetaCoV/Singapore/2/2020
82 - BetaCoV/Belgium/GHB-0302 1/2020
22 - BetaCoV/Shenzhen/HKU-SZ-005/2020
78 - BetaCov/France/IDF0626/2020
78 - BetaCov/France/IDF0626/2020
19 - BetaCov/Wuhan/WH04/2020
80 - BetaCoV/Taiwan/NTU01/2020
40 - BetaCoV/Beijing/IV DC-BJ-005/2020
50 - BetaCoV/Guangdong/20SF174/2020
56 - BetaCoV/USA/CA1/2020
65 - BetaCoV/Korea/KCDC03/2020
80 - BetaCoV/Taiwan/NTU01/2020
35 - BetaCoV/Guangdong/20SF028/2020
68 - BetaCoV/Singapore/2/2020
8 - BetaCoV/Wuhan/WIV06/2019
35 - BetaCoV/Guangdong/20SF028/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
62 - BetaCoV/Australia/NS WO 1/2020
78 - BetaCov/France/IDF0626/2020
64 - BetaCoV/Japan/AI/I-004/2020
71 - BetaCoV/England/01/2020
17 - BetaCoV/China/WHU01/2020
66 - BetaCoV/USA/WA1-A12/2020
60 - BetaCoV/Singapore/ 1/2020
44 - BetaCoV/Jiangsu/IVDC-JS-00 1/2020
80 - BetaCoV/Taiwan/NTU01/2020
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
79 - BetaCoV/Australia/QLD02/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
80 - BetaCoV/Taiwan/NTU01/2020
82 - BetaCoV/Belgium/GHB-0302 1/2020
37 - BetaCoV/Yunnan/IVDC- Y N-003/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
79 - BetaCoV/Australia/QLD02/2020
32 - BetaCoV/Zhejiang/WZ-0 1/2020
8 - BetaCoV/Wuhan/WIV06/2019
17 - BetaCoV/China/WHU01/2020
20 - BetaCoV/Nonthaburi/6 1/2020
32 - BetaCoV/Zhejiang/WZ-0 1/2020
60 - BetaCoV/Singapore/ 1/2020
80 - BetaCoV/Taiwan/NTU01/2020
20 - BetaCoV/Nonthaburi/6 1/2020
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
65 - BetaCoV/Korea/KCDC03/2020
65 - BetaCoV/Korea/KCDC03/2020
9 - BetaCoV/Wuhan/WIV07/2019
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
11 - BetaCoV/Wuhan/IPBCAMS-WH-04/2019
33 - BetaCoV/Shenzhen/SZTH-003/2020
37 - BetaCoV/Yunnan/IVDC- Y N-003/2020
40 - BetaCoV/Beijing/IV DC-BJ-005/2020
70 - BetaCoV/Australia/QLD0O1/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
59 - BetaCoV/France/IDF0373/2020
10 - BetaCoV/Wuhan/HBCDC-HB-01/2019
16 - BetaCov/Wuhan/WH03/2020
81 - BetaCoV/Singapore/3/2020
10 - BetaCoV/Wuhan/HBCDC-HB-01/2019
11 - BetaCoV/Wuhan/IPBCAMS-WH-04/2019
17 - BetaCoV/China/WHU01/2020
78 - BetaCov/France/IDF0626/2020
19 - BetaCov/Wuhan/WH04/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
36 - BetaCoV/Zhejiang/WZ-02/2020
70 - BetaCoV/Australia/QLD0O1/2020
8 - BetaCoV/Wuhan/WIV06/2019

546
546
545
544
544
544
544
544
544
544
540
539
539
538
536
536
535
535
534
534
534
533
533
532
532
532
532
531
530
530
529
528
526
526
526
525
525
525
524
524
523
522
522
521
519
518
517
516
516
516
516
515
514
512
512
511
511
510
509
509
508
507
505
505
505
504
503
502
501
497
497
497
497
496
494
493
493
493
492
491
489
488
488
488
488
487
485
485
484
483
483
482
482
482
482
481
481
481
481
480

14/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Table 5. Edge weight between distinct nucleotide sequences in the Transcendental
Information Cascade we constructed (contd.).
Source sequence

Target sequence

Edge weight

57 - BetaCoV/Guangdong/20SF201/2020
77 - BetaCo V/France/IDF05 15/2020
16 - BetaCov/Wuhan/WH03/2020
6 - BetaCoV/Wuhan/WIV02/2019
58 - BetaCo V/France/IDF0372/2020
57 - BetaCoV/Guangdong/20SF201/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
34 - BetaCoV/Shenzhen/SZTH-004/2020
36 - BetaCoV/Zhejiang/WZ-02/2020
57 - BetaCoV/Guangdong/20SF201/2020
79 - BetaCoV/Australia/QLD02/2020
34 - BetaCoV/Shenzhen/SZTH-004/2020
81 - BetaCoV/Singapore/3/2020
7 - BetaCoV/Wuhan/WIV05/2019
9 - BetaCoV/Wuhan/WIV07/2019
6 - BetaCoV/Wuhan/WIV02/2019
56 - BetaCoV/USA/CA1/2020
78 - BetaCov/France/IDF0626/2020
44 - BetaCoV/Jiangsu/IVDC-JS-00 1/2020
36 - BetaCoV/Zhejiang/WZ-02/2020
2 - BetaCov/Wuhan/WHO01/2019
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
6 - BetaCoV/Wuhan/WIV02/2019
65 - BetaCoV/Korea/KCDC03/2020
9 - BetaCoV/Wuhan/WIV07/2019
77 - BetaCo V/France/IDF05 15/2020
64 - BetaCoV/Japan/AI/I-004/2020
19 - BetaCov/Wuhan/WH04/2020
38 - BetaCoV/Guangdong/20SF040/2020
6 - BetaCoV/Wuhan/WIV02/2019
32 - BetaCoV/Zhejiang/WZ-0 1/2020
31 - BetaCoV/Sichuan/ITVDC-SC-00 1/2020
55 - BetaCoV/Taiwan/2/2020
10 - BetaCoV/Wuhan/HBCDC-HB-01/2019
2 - BetaCov/Wuhan/WHO01/2019
69 - BetaCoV/Germany/BavPat 1/2020
55 - BetaCoV/Taiwan/2/2020
7 - BetaCoV/Wuhan/WIV05/2019
32 - BetaCoV/Zhejiang/WZ-0 1/2020
59 - BetaCoV/France/IDF0373/2020
7 - BetaCoV/Wuhan/WIV05/2019
9 - BetaCoV/Wuhan/WIV07/2019
36 - BetaCoV/Zhejiang/WZ-02/2020
58 - BetaCo V/France/IDF0372/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
34 - BetaCoV/Shenzhen/SZTH-004/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
59 - BetaCoV/France/IDF0373/2020
19 - BetaCov/Wuhan/WH04/2020
62 - BetaCoV/Australia/NS WO 1/2020
64 - BetaCoV/Japan/AI/I-004/2020
36 - BetaCoV/Zhejiang/WZ-02/2020
9 - BetaCoV/Wuhan/WIV07/2019
5 - BetaCoV/Wuhan/WIV04/2019
6 - BetaCoV/Wuhan/WIV02/2019
7 - BetaCoV/Wuhan/WIV05/2019
8 - BetaCoV/Wuhan/WIV06/2019
18 - BetaCoV/China/WHU02/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
57 - BetaCoV/Guangdong/20SF201/2020
64 - BetaCoV/Japan/AI/I-004/2020
69 - BetaCoV/Germany/BavPat 1/2020
16 - BetaCov/Wuhan/WH03/2020
8 - BetaCoV/Wuhan/WIV06/2019
34 - BetaCoV/Shenzhen/SZTH-004/2020
44 - BetaCoV/Jiangsu/IVDC-JS-00 1/2020
64 - BetaCoV/Japan/AI/I-004/2020
32 - BetaCoV/Zhejiang/WZ-0 1/2020
2 - BetaCov/Wuhan/WHO01/2019
9 - BetaCoV/Wuhan/WIV07/2019
36 - BetaCoV/Zhejiang/WZ-02/2020
6 - BetaCoV/Wuhan/WIV02/2019
70 - BetaCoV/Australia/QLD0O1/2020
16 - BetaCov/Wuhan/WH03/2020
9 - BetaCoV/Wuhan/WIV07/2019
6 - BetaCoV/Wuhan/WIV02/2019
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
19 - BetaCov/Wuhan/WH04/2020
2 - BetaCov/Wuhan/WHO01/2019
9 - BetaCoV/Wuhan/WIV07/2019
2 - BetaCov/Wuhan/WHO01/2019
34 - BetaCoV/Shenzhen/SZTH-004/2020
44 - BetaCoV/Jiangsu/IVDC-JS-00 1/2020
8 - BetaCoV/Wuhan/WIV06/2019
36 - BetaCoV/Zhejiang/WZ-02/2020
57 - BetaCoV/Guangdong/20SF201/2020
77 - BetaCo V/France/IDF05 15/2020
8 - BetaCoV/Wuhan/WIV06/2019
9 - BetaCoV/Wuhan/WIV07/2019
2 - BetaCov/Wuhan/WHO01/2019
32 - BetaCoV/Zhejiang/WZ-0 1/2020
9 - BetaCoV/Wuhan/WIV07/2019
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
6 - BetaCoV/Wuhan/WIV02/2019
16 - BetaCov/Wuhan/WH03/2020
59 - BetaCoV/France/IDF0373/2020
7 - BetaCoV/Wuhan/WIV05/2019
8 - BetaCoV/Wuhan/WIV06/2019
7 - BetaCoV/Wuhan/WIV05/2019
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
36 - BetaCoV/Zhejiang/WZ-02/2020
7 - BetaCoV/Wuhan/WIV05/2019
16 - BetaCov/Wuhan/WH03/2020

59 - BetaCoV/France/IDF0373/2020
80 - BetaCoV/Taiwan/NTU01/2020
22 - BetaCoV/Shenzhen/HKU-SZ-005/2020
64 - BetaCoV/Japan/AI/I-004/2020
68 - BetaCoV/Singapore/2/2020
79 - BetaCoV/Australia/QLD02/2020
32 - BetaCoV/Zhejiang/WZ-0 1/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
62 - BetaCoV/Australia/NS WO 1/2020
81 - BetaCoV/Singapore/3/2020
65 - BetaCoV/Korea/KCDC03/2020
82 - BetaCoV/Belgium/GHB-0302 1/2020
8 - BetaCoV/Wuhan/WIV06/2019
10 - BetaCoV/Wuhan/HBCDC-HB-01/2019
17 - BetaCoV/China/WHU01/2020
59 - BetaCoV/France/IDF0373/2020
79 - BetaCoV/Australia/QLD02/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
7 - BetaCoV/Wuhan/WIV05/2019
50 - BetaCoV/Guangdong/20SF174/2020
62 - BetaCoV/Australia/NS WO 1/2020
69 - BetaCoV/Germany/BavPat 1/2020
16 - BetaCov/Wuhan/WH03/2020
79 - BetaCoV/Australia/QLD02/2020
80 - BetaCoV/Taiwan/NTU01/2020
32 - BetaCoV/Zhejiang/WZ-0 1/2020
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
37 - BetaCoV/Yunnan/IVDC- Y N-003/2020
36 - BetaCoV/Zhejiang/WZ-02/2020
65 - BetaCoV/Korea/KCDC03/2020
19 - BetaCov/Wuhan/WH04/2020
19 - BetaCov/Wuhan/WH04/2020
81 - BetaCoV/Singapore/3/2020
59 - BetaCoV/France/IDF0373/2020
9 - BetaCoV/Wuhan/WIV07/2019
36 - BetaCoV/Zhejiang/WZ-02/2020
81 - BetaCoV/Singapore/3/2020
10 - BetaCoV/Wuhan/HBCDC-HB-01/2019
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
64 - BetaCoV/Japan/AI/I-004/2020
64 - BetaCoV/Japan/AI/I-004/2020
40 - BetaCoV/Beijing/IV DC-BJ-005/2020
59 - BetaCoV/France/IDF0373/2020
62 - BetaCoV/Australia/NS WO 1/2020
80 - BetaCoV/Taiwan/NTU01/2020
40 - BetaCoV/Beijing/IV DC-BJ-005/2020
65 - BetaCoV/Korea/KCDC03/2020
68 - BetaCoV/Singapore/2/2020
81 - BetaCoV/Singapore/3/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
9 - BetaCoV/Wuhan/WIV07/2019
33 - BetaCoV/Shenzhen/SZTH-003/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
17 - BetaCoV/China/WHU01/2020
36 - BetaCoV/Zhejiang/WZ-02/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
58 - BetaCo V/France/IDF0372/2020
64 - BetaCoV/Japan/AI/I-004/2020
78 - BetaCov/France/IDF0626/2020
80 - BetaCoV/Taiwan/NTU01/2020
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
64 - BetaCoV/Japan/AI/I-004/2020
62 - BetaCoV/Australia/NS WO 1/2020
81 - BetaCoV/Singapore/3/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
16 - BetaCov/Wuhan/WH03/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
59 - BetaCoV/France/IDF0373/2020
79 - BetaCoV/Australia/QLD02/2020
81 - BetaCoV/Singapore/3/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
16 - BetaCov/Wuhan/WH03/2020
81 - BetaCoV/Singapore/3/2020
50 - BetaCoV/Guangdong/20SF174/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
19 - BetaCov/Wuhan/WH04/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
62 - BetaCoV/Australia/NS WO 1/2020
58 - BetaCo V/France/IDF0372/2020
80 - BetaCoV/Taiwan/NTU01/2020
62 - BetaCoV/Australia/NS WO 1/2020
65 - BetaCoV/Korea/KCDC03/2020
82 - BetaCoV/Belgium/GHB-0302 1/2020
19 - BetaCov/Wuhan/WH04/2020
50 - BetaCoV/Guangdong/20SF174/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
50 - BetaCoV/Guangdong/20SF174/2020
62 - BetaCoV/Australia/NS WO 1/2020
80 - BetaCoV/Taiwan/NTU01/2020
32 - BetaCoV/Zhejiang/WZ-0 1/2020
65 - BetaCoV/Korea/KCDC03/2020
79 - BetaCoV/Australia/QLD02/2020
36 - BetaCoV/Zhejiang/WZ-02/2020
32 - BetaCoV/Zhejiang/WZ-0 1/2020
32 - BetaCoV/Zhejiang/WZ-0 1/2020
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
79 - BetaCoV/Australia/QLD02/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
81 - BetaCoV/Singapore/3/2020

479
479
478
478
478
478
477
477
477
477
477
476
474
472
472
472
472
472
471
470
469
469
469
469
468
468
468
467
467
466
466
465
464
463
462
462
461
460
460
460
458
458
456
456
455
455
454
453
452
452
451
448
446
445
445
444
443
443
442
442
442
441
441
439
439
439
437
437
436
434
434
433
432
432
431
430
428
428
427
425
424
424
423
422
422
420
420
420
419
419
418
417
417
413
412
411
410
409
408
407
407
407
400
400

15/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Table 6. Edge weight between distinct nucleotide sequences in the Transcendental
Information Cascade we constructed (contd.).
Source sequence

Target sequence

Edge weight

9 - BetaCoV/Wuhan/WIV07/2019
8 - BetaCoV/Wuhan/WIV06/2019
8 - BetaCoV/Wuhan/WIV06/2019
16 - BetaCov/Wuhan/WH03/2020
2 - BetaCov/Wuhan/WHO01/2019
6 - BetaCoV/Wuhan/WIV02/2019
8 - BetaCoV/Wuhan/WIV06/2019
7 - BetaCoV/Wuhan/WIV05/2019
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
55 - BetaCoV/Taiwan/2/2020
34 - BetaCoV/Shenzhen/SZTH-004/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
6 - BetaCoV/Wuhan/WIV02/2019
9 - BetaCoV/Wuhan/WIV07/2019
16 - BetaCov/Wuhan/WH03/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
8 - BetaCoV/Wuhan/WIV06/2019
19 - BetaCov/Wuhan/WH04/2020
2 - BetaCov/Wuhan/WHO01/2019
19 - BetaCov/Wuhan/WH04/2020
8 - BetaCoV/Wuhan/WIV06/2019
9 - BetaCoV/Wuhan/WIV07/2019
16 - BetaCov/Wuhan/WH03/2020
44 - BetaCoV/Jiangsu/IVDC-JS-00 1/2020
7 - BetaCoV/Wuhan/WIV05/2019
9 - BetaCoV/Wuhan/WIV07/2019
8 - BetaCoV/Wuhan/WIV06/2019
2 - BetaCov/Wuhan/WHO01/2019
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
7 - BetaCoV/Wuhan/WIV05/2019
2 - BetaCov/Wuhan/WHO01/2019
2 - BetaCov/Wuhan/WHO01/2019
9 - BetaCoV/Wuhan/WIV07/2019
76 - BetaCoV/USA/CA5/2020
6 - BetaCoV/Wuhan/WIV02/2019
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
2 - BetaCov/Wuhan/WHO01/2019
6 - BetaCoV/Wuhan/WIV02/2019
7 - BetaCoV/Wuhan/WIV05/2019
36 - BetaCoV/Zhejiang/WZ-02/2020
19 - BetaCov/Wuhan/WH04/2020
2 - BetaCov/Wuhan/WHO01/2019
6 - BetaCoV/Wuhan/WIV02/2019
33 - BetaCoV/Shenzhen/SZTH-003/2020
18 - BetaCoV/China/WHU02/2020
2 - BetaCov/Wuhan/WHO01/2019
47 - BetaCoV/Chonggqing/Y C0 1/2020
55 - BetaCoV/Taiwan/2/2020
32 - BetaCoV/Zhejiang/WZ-0 1/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
60 - BetaCoV/Singapore/ 1/2020
2 - BetaCov/Wuhan/WHO01/2019
9 - BetaCoV/Wuhan/WIV07/2019
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
47 - BetaCoV/Chonggqing/Y C0 1/2020
58 - BetaCo V/France/IDF0372/2020
57 - BetaCoV/Guangdong/20SF201/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
61 - BetaCoV/Chonggqing/ZX0 1/2020
59 - BetaCoV/France/IDF0373/2020
47 - BetaCoV/Chonggqing/Y C0 1/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
72 - BetaCoV/England/02/2020
61 - BetaCoV/Chonggqing/ZX0 1/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
38 - BetaCoV/Guangdong/20SF040/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
47 - BetaCoV/Chonggqing/Y C0 1/2020
7 - BetaCoV/Wuhan/WIV05/2019
31 - BetaCoV/Sichuan/ITVDC-SC-00 1/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
32 - BetaCoV/Zhejiang/WZ-0 1/2020
34 - BetaCoV/Shenzhen/SZTH-004/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
19 - BetaCov/Wuhan/WH04/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
44 - BetaCoV/Jiangsu/IVDC-JS-00 1/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
61 - BetaCoV/Chonggqing/ZX0 1/2020
16 - BetaCov/Wuhan/WH03/2020
61 - BetaCoV/Chonggqing/ZX0 1/2020
8 - BetaCoV/Wuhan/WIV06/2019
36 - BetaCoV/Zhejiang/WZ-02/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
61 - BetaCoV/Chonggqing/ZX0 1/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
30 - BetaCoV/Guangdong/20SF025/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
8 - BetaCoV/Wuhan/WIV06/2019
16 - BetaCov/Wuhan/WH03/2020
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
19 - BetaCov/Wuhan/WH04/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
61 - BetaCoV/Chonggqing/ZX0 1/2020

36
62
81
62
36
36
42
50
65
80
79
65
50
64
79
64
79
65
42
80
65
79
64
64
80
80
64
80
79
65
50
62
81
81
65
81
79
80
81
65
81
81
81
36
34
64
55
61
34
35
62
34
34
79
50
61
61
62
81
61
58
42
74
78
50
47
47
59
34
34
64
47
47
47
47
47
47
34
80
34
64
34
47
40
59
80
37
45
68
80
34
62
47
47
47
64
34
65
65

399
399
398
397
395
395
393
393
393
389
382
380
376
375
374
369
369
367
360
360
358
358
354
346
346
344
343
342
341
339
333
331
331
328
327
325
323
309
308
295
290
284
265
256
239
238
237
225
220
207
204
201
196
194
192
192
185
185
184
183
179
178
178
178
177
175
174
171
169
165
164
162
162
160
159
159
159
158
158
157
157
155
155
154
154
154
152
152
150
149
148
148
147
147
147
147
146
143
142

-

BetaCoV/Zhejiang/WZ-02/2020
BetaCoV/Australia/NS WO 1/2020
BetaCoV/Singapore/3/2020
BetaCoV/Australia/NS WO 1/2020
BetaCoV/Zhejiang/WZ-02/2020
BetaCoV/Zhejiang/WZ-02/2020
BetaCoV/Hangzhou/HZCDC000 1/2020
BetaCoV/Guangdong/20SF174/2020
BetaCoV/Korea/KCDC03/2020
BetaCoV/Taiwan/NTU01/2020
BetaCoV/Australia/QLD02/2020
BetaCoV/Korea/KCDC03/2020
BetaCoV/Guangdong/20SF174/2020
BetaCoV/Japan/AI/I-004/2020
BetaCoV/Australia/QLD02/2020
BetaCoV/Japan/AI/I-004/2020
BetaCoV/Australia/QLD02/2020
BetaCoV/Korea/KCDC03/2020
BetaCoV/Hangzhou/HZCDC000 1/2020
BetaCoV/Taiwan/NTU01/2020
BetaCoV/Korea/KCDC03/2020
BetaCoV/Australia/QLD02/2020
BetaCoV/Japan/AI/I-004/2020
BetaCoV/Japan/AI/I-004/2020
BetaCoV/Taiwan/NTU01/2020
BetaCoV/Taiwan/NTU01/2020
BetaCoV/Japan/AI/I-004/2020
BetaCoV/Taiwan/NTU01/2020
BetaCoV/Australia/QLD02/2020
BetaCoV/Korea/KCDC03/2020
BetaCoV/Guangdong/20SF174/2020
BetaCoV/Australia/NS WO 1/2020
BetaCoV/Singapore/3/2020
BetaCoV/Singapore/3/2020
BetaCoV/Korea/KCDC03/2020
BetaCoV/Singapore/3/2020
BetaCoV/Australia/QLD02/2020
BetaCoV/Taiwan/NTU01/2020
BetaCoV/Singapore/3/2020
BetaCoV/Korea/KCDC03/2020
BetaCoV/Singapore/3/2020
BetaCoV/Singapore/3/2020
BetaCoV/Singapore/3/2020
BetaCoV/Zhejiang/WZ-02/2020
BetaCoV/Shenzhen/SZTH-004/2020
BetaCoV/Japan/AI/I-004/2020
BetaCoV/Taiwan/2/2020
BetaCoV/Chonggqing/ZX0 1/2020
BetaCoV/Shenzhen/SZTH-004/2020
BetaCoV/Guangdong/20SF028/2020
BetaCoV/Australia/NS WO 1/2020
BetaCoV/Shenzhen/SZTH-004/2020
BetaCoV/Shenzhen/SZTH-004/2020
BetaCoV/Australia/QLD02/2020
BetaCoV/Guangdong/20SF174/2020
BetaCoV/Chonggqing/ZX0 1/2020
BetaCoV/Chonggqing/ZX0 1/2020
BetaCoV/Australia/NS WO 1/2020
BetaCoV/Singapore/3/2020
BetaCoV/Chonggqing/ZX0 1/2020
BetaCo V/France/IDF0372/2020
BetaCoV/Hangzhou/HZCDC000 1/2020
BetaCoV/USA/CA3/2020
BetaCov/France/IDF0626/2020
BetaCoV/Guangdong/20SF174/2020
BetaCoV/Chonggqing/Y C0 1/2020
BetaCoV/Chonggqing/Y C0 1/2020
BetaCoV/France/IDF0373/2020
BetaCoV/Shenzhen/SZTH-004/2020
BetaCoV/Shenzhen/SZTH-004/2020
BetaCoV/Japan/AI/I-004/2020
BetaCoV/Chonggqing/Y C0 1/2020
BetaCoV/Chonggqing/Y C0 1/2020
BetaCoV/Chonggqing/Y C0 1/2020
BetaCoV/Chonggqing/Y C0 1/2020
BetaCoV/Chonggqing/Y C0 1/2020
BetaCoV/Chonggqing/Y C0 1/2020
BetaCoV/Shenzhen/SZTH-004/2020
BetaCoV/Taiwan/NTU01/2020
BetaCoV/Shenzhen/SZTH-004/2020
BetaCoV/Japan/AI/I-004/2020
BetaCoV/Shenzhen/SZTH-004/2020
BetaCoV/Chonggqing/Y C0 1/2020
BetaCoV/Beijing/IV DC-BJ-005/2020
BetaCoV/France/IDF0373/2020
BetaCoV/Taiwan/NTU01/2020
BetaCoV/Yunnan/IVDC- Y N-003/2020
BetaCoV/Zhejiang/Hangzhou- 1/2020
BetaCoV/Singapore/2/2020
BetaCoV/Taiwan/NTU01/2020
BetaCoV/Shenzhen/SZTH-004/2020
BetaCoV/Australia/NS WO 1/2020
BetaCoV/Chonggqing/Y C0 1/2020
BetaCoV/Chonggqing/Y C0 1/2020
BetaCoV/Chonggqing/Y C0 1/2020
BetaCoV/Japan/AI/I-004/2020
BetaCoV/Shenzhen/SZTH-004/2020
BetaCoV/Korea/KCDC03/2020
BetaCoV/Korea/KCDC03/2020

16/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Table 7. Edge weight between distinct nucleotide sequences in the Transcendental
Information Cascade we constructed (contd.).
Source sequence

Target sequence

Edge weight

61 - BetaCoV/Chonggqing/ZX0 1/2020
6 - BetaCoV/Wuhan/WIV02/2019
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
9 - BetaCoV/Wuhan/WIV07/2019
6 - BetaCoV/Wuhan/WIV02/2019
2 - BetaCov/Wuhan/WHO01/2019
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
36 - BetaCoV/Zhejiang/WZ-02/2020
38 - BetaCoV/Guangdong/20SF040/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
7 - BetaCoV/Wuhan/WIV05/2019
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
60 - BetaCoV/Singapore/ 1/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
8 - BetaCoV/Wuhan/WIV06/2019
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
32 - BetaCoV/Zhejiang/WZ-0 1/2020
16 - BetaCov/Wuhan/WH03/2020
23 - BetaCoV/Jiangxi/IV DC-JX-002/2020
6 - BetaCoV/Wuhan/WIV02/2019
19 - BetaCov/Wuhan/WH04/2020
2 - BetaCov/Wuhan/WHO01/2019
9 - BetaCoV/Wuhan/WIV07/2019
34 - BetaCoV/Shenzhen/SZTH-004/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
7 - BetaCoV/Wuhan/WIV05/2019
40 - BetaCoV/Beijing/IV DC-BJ-005/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
18 - BetaCoV/China/WHU02/2020
53 - BetaCo V/Foshan/20SF2 10/2020
40 - BetaCoV/Beijing/IV DC-BJ-005/2020
56 - BetaCoV/USA/CA1/2020
41 - BetaCoV/USA/WA 1/2020
67 - BetaCoV/USA/W A 1-F6/2020
22 - BetaCoV/Shenzhen/HKU-SZ-005/2020
67 - BetaCoV/USA/W A 1-F6/2020
12 - BetaCoV/Wuhan/IPBCAMS-WH-03/2019
26 - BetaCoV/Shenzhen/SZTH-002/2020
43 - BetaCoV/Shandong/IVDC-SD-00 1/2020
55 - BetaCoV/Taiwan/2/2020
15 - BetaCoV/Wuhan/IPBCAMS-WH-05/2020
39 - BetaCoV/Chongqing/IVDC-CQ-00 1/2020
28 - BetaCoV/Guangdong/20SFO0 13/2020
49 - BetaCoV/USA/AZ1/2020
14 - BetaCoV/Wuhan/IV DC-HB-04/2020
24 - BetaCoV/Nonthaburi/74/2020
29 - BetaCoV/Guangdong/20SFO0 14/2020
31 - BetaCoV/Sichuan/ITVDC-SC-00 1/2020
19 - BetaCov/Wuhan/WH04/2020
73 - BetaCoV/Finland/1/2020
1 - BetaCoV/Wuhan/IPBCAMS-WH-01/2019
40 - BetaCoV/Beijing/IV DC-BJ-005/2020
56 - BetaCoV/USA/CA1/2020
14 - BetaCoV/Wuhan/IV DC-HB-04/2020
37 - BetaCoV/Yunnan/IVDC- Y N-003/2020
43 - BetaCoV/Shandong/IVDC-SD-00 1/2020
24 - BetaCoV/Nonthaburi/74/2020
3 - BetaCoV/Wuhan/IV DC-HB-01/2019
13 - BetaCoV/Wuhan/IPBCAMS-WH-02/2019
47 - BetaCoV/Chonggqing/Y C0 1/2020
50 - BetaCoV/Guangdong/20SF174/2020
51 - BetaCoV/Guangzhou/20SF206/2020
48 - BetaCoV/USA/CA2/2020
48 - BetaCoV/USA/CA2/2020
61 - BetaCoV/Chonggqing/ZX0 1/2020
63 - BetaCoV/Australia/VICO1/2020
72 - BetaCoV/England/02/2020
75 - BetaCoV/USA/CA4/2020
41 - BetaCoV/USA/WA 1/2020
47 - BetaCoV/Chonggqing/Y C0 1/2020
40 - BetaCoV/Beijing/IV DC-BJ-005/2020
38 - BetaCoV/Guangdong/20SF040/2020
34 - BetaCoV/Shenzhen/SZTH-004/2020
56 - BetaCoV/USA/CA1/2020
58 - BetaCo V/France/IDF0372/2020
63 - BetaCoV/Australia/VICO1/2020
11 - BetaCoV/Wuhan/IPBCAMS-WH-04/2019
19 - BetaCov/Wuhan/WH04/2020
22 - BetaCoV/Shenzhen/HKU-SZ-005/2020
23 - BetaCoV/Jiangxi/IV DC-JX-002/2020
25 - BetaCoV/Shenzhen/SZTH-00 1/2020
25 - BetaCoV/Shenzhen/SZTH-00 1/2020
26 - BetaCoV/Shenzhen/SZTH-002/2020
26 - BetaCoV/Shenzhen/SZTH-002/2020
31 - BetaCoV/Sichuan/ITVDC-SC-00 1/2020
38 - BetaCoV/Guangdong/20SF040/2020
40 - BetaCoV/Beijing/IV DC-BJ-005/2020
26 - BetaCoV/Shenzhen/SZTH-002/2020
41 - BetaCoV/USA/WA 1/2020
43 - BetaCoV/Shandong/IVDC-SD-00 1/2020
46 - BetaCoV/USA/IL 1/2020
52 - BetaCo V/Foshan/20SF207/2020
30 - BetaCoV/Guangdong/20SF025/2020
2 - BetaCov/Wuhan/WHO01/2019
7 - BetaCoV/Wuhan/WIV05/2019
9 - BetaCoV/Wuhan/WIV07/2019
33 - BetaCoV/Shenzhen/SZTH-003/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
48 - BetaCoV/USA/CA2/2020
57 - BetaCoV/Guangdong/20SF201/2020

79 - BetaCoV/Australia/QLD02/2020
47 - BetaCoV/Chonggqing/Y C0 1/2020
58 - BetaCo V/France/IDF0372/2020
59 - BetaCoV/France/IDF0373/2020
47 - BetaCoV/Chonggqing/Y C0 1/2020
34 - BetaCoV/Shenzhen/SZTH-004/2020
47 - BetaCoV/Chonggqing/Y C0 1/2020
65 - BetaCoV/Korea/KCDC03/2020
55 - BetaCoV/Taiwan/2/2020
55 - BetaCoV/Taiwan/2/2020
55 - BetaCoV/Taiwan/2/2020
79 - BetaCoV/Australia/QLD02/2020
47 - BetaCoV/Chonggqing/Y C0 1/2020
55 - BetaCoV/Taiwan/2/2020
66 - BetaCoV/USA/WA1-A12/2020
81 - BetaCoV/Singapore/3/2020
55 - BetaCoV/Taiwan/2/2020
55 - BetaCoV/Taiwan/2/2020
55 - BetaCoV/Taiwan/2/2020
55 - BetaCoV/Taiwan/2/2020
26 - BetaCoV/Shenzhen/SZTH-002/2020
55 - BetaCoV/Taiwan/2/2020
55 - BetaCoV/Taiwan/2/2020
55 - BetaCoV/Taiwan/2/2020
55 - BetaCoV/Taiwan/2/2020
55 - BetaCoV/Taiwan/2/2020
68 - BetaCoV/Singapore/2/2020
55 - BetaCoV/Taiwan/2/2020
68 - BetaCoV/Singapore/2/2020
81 - BetaCoV/Singapore/3/2020
44 - BetaCoV/Jiangsu/IVDC-JS-00 1/2020
57 - BetaCoV/Guangdong/20SF201/2020
55 - BetaCoV/Taiwan/2/2020
66 - BetaCoV/USA/WA1-A12/2020
46 - BetaCoV/USA/IL 1/2020
74 - BetaCoV/USA/CA3/2020
25 - BetaCoV/Shenzhen/SZTH-00 1/2020
73 - BetaCoV/Finland/1/2020
14 - BetaCoV/Wuhan/IV DC-HB-04/2020
37 - BetaCoV/Yunnan/IVDC- Y N-003/2020
48 - BetaCoV/USA/CA2/2020
77 - BetaCo V/France/IDF05 15/2020
23 - BetaCoV/Jiangxi/IV DC-JX-002/2020
43 - BetaCoV/Shandong/IVDC-SD-00 1/2020
30 - BetaCoV/Guangdong/20SF025/2020
60 - BetaCoV/Singapore/ 1/2020
22 - BetaCoV/Shenzhen/HKU-SZ-005/2020
29 - BetaCoV/Guangdong/20SFO0 14/2020
35 - BetaCoV/Guangdong/20SF028/2020
56 - BetaCoV/USA/CA1/2020
63 - BetaCoV/Australia/VICO1/2020
76 - BetaCoV/USA/CA5/2020
12 - BetaCoV/Wuhan/IPBCAMS-WH-03/2019
43 - BetaCoV/Shandong/IVDC-SD-00 1/2020
61 - BetaCoV/Chonggqing/ZX0 1/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
41 - BetaCoV/USA/WA 1/2020
47 - BetaCoV/Chonggqing/Y C0 1/2020
58 - BetaCo V/France/IDF0372/2020
5 - BetaCoV/Wuhan/WIV04/2019
15 - BetaCoV/Wuhan/IPBCAMS-WH-05/2020
49 - BetaCoV/USA/AZ1/2020
52 - BetaCo V/Foshan/20SF207/2020
53 - BetaCo V/Foshan/20SF2 10/2020
56 - BetaCoV/USA/CA1/2020
60 - BetaCoV/Singapore/ 1/2020
66 - BetaCoV/USA/WA1-A12/2020
73 - BetaCoV/Finland/1/2020
82 - BetaCoV/Belgium/GHB-0302 1/2020
82 - BetaCoV/Belgium/GHB-0302 1/2020
47 - BetaCoV/Chonggqing/Y C0 1/2020
51 - BetaCoV/Guangzhou/20SF206/2020
62 - BetaCoV/Australia/NS WO 1/2020
78 - BetaCov/France/IDF0626/2020
51 - BetaCoV/Guangzhou/20SF206/2020
63 - BetaCoV/Australia/VICO1/2020
63 - BetaCoV/Australia/VICO1/2020
78 - BetaCov/France/IDF0626/2020
13 - BetaCoV/Wuhan/IPBCAMS-WH-02/2019
25 - BetaCoV/Shenzhen/SZTH-00 1/2020
26 - BetaCoV/Shenzhen/SZTH-002/2020
31 - BetaCoV/Sichuan/ITVDC-SC-00 1/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
39 - BetaCoV/Chongqing/IVDC-CQ-00 1/2020
40 - BetaCoV/Beijing/IV DC-BJ-005/2020
41 - BetaCoV/USA/WA 1/2020
41 - BetaCoV/USA/WA 1/2020
44 - BetaCoV/Jiangsu/IVDC-JS-00 1/2020
47 - BetaCoV/Chonggqing/Y C0 1/2020
49 - BetaCoV/USA/AZ1/2020
49 - BetaCoV/USA/AZ1/2020
49 - BetaCoV/USA/AZ1/2020
49 - BetaCoV/USA/AZ1/2020
57 - BetaCoV/Guangdong/20SF201/2020
58 - BetaCo V/France/IDF0372/2020
63 - BetaCoV/Australia/VICO1/2020
63 - BetaCoV/Australia/VICO1/2020
63 - BetaCoV/Australia/VICO1/2020
63 - BetaCoV/Australia/VICO1/2020
63 - BetaCoV/Australia/VICO1/2020
63 - BetaCoV/Australia/VICO1/2020
63 - BetaCoV/Australia/VICO1/2020

139
138
138
133
132
129
124
120
119
118
114
105
103
96
95
95
93
88
84
83
72
60
59
58
57
55
53
49
47
44
35
35
34
32
31
28
24
22
21
20
18
18
14
13
12
12
11
9
9
9
9
9
8
8
8
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3

17/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Table 8. Edge weight between distinct nucleotide sequences in the Transcendental
Information Cascade we constructed (contd.).
Source sequence

Target sequence

Edge weight

47 - BetaCoV/Chonggqing/Y C0 1/2020
63 - BetaCoV/Australia/VICO1/2020
63 - BetaCoV/Australia/VICO1/2020
71 - BetaCoV/England/01/2020
2 - BetaCov/Wuhan/WHO01/2019
16 - BetaCov/Wuhan/WH03/2020
12 - BetaCoV/Wuhan/IPBCAMS-WH-03/2019
22 - BetaCoV/Shenzhen/HKU-SZ-005/2020
23 - BetaCoV/Jiangxi/IV DC-JX-002/2020
2 - BetaCov/Wuhan/WHO01/2019
18 - BetaCoV/China/WHU02/2020
36 - BetaCoV/Zhejiang/WZ-02/2020
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
34 - BetaCoV/Shenzhen/SZTH-004/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
40 - BetaCoV/Beijing/IV DC-BJ-005/2020
2 - BetaCov/Wuhan/WHO01/2019
49 - BetaCoV/USA/AZ1/2020
43 - BetaCoV/Shandong/IVDC-SD-00 1/2020
8 - BetaCoV/Wuhan/WIV06/2019
36 - BetaCoV/Zhejiang/WZ-02/2020
55 - BetaCoV/Taiwan/2/2020
59 - BetaCoV/France/IDF0373/2020
63 - BetaCoV/Australia/VICO1/2020
19 - BetaCov/Wuhan/WH04/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
34 - BetaCoV/Shenzhen/SZTH-004/2020
36 - BetaCoV/Zhejiang/WZ-02/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
68 - BetaCoV/Singapore/2/2020
65 - BetaCoV/Korea/KCDC03/2020
22 - BetaCoV/Shenzhen/HKU-SZ-005/2020
25 - BetaCoV/Shenzhen/SZTH-00 1/2020
56 - BetaCoV/USA/CA1/2020
63 - BetaCoV/Australia/VICO1/2020
48 - BetaCoV/USA/CA2/2020
52 - BetaCo V/Foshan/20SF207/2020
65 - BetaCoV/Korea/KCDC03/2020
67 - BetaCoV/USA/W A 1-F6/2020
5 - BetaCoV/Wuhan/WIV04/2019
8 - BetaCoV/Wuhan/WIV06/2019
2 - BetaCov/Wuhan/WHO01/2019
2 - BetaCov/Wuhan/WHO01/2019
13 - BetaCoV/Wuhan/IPBCAMS-WH-02/2019
6 - BetaCoV/Wuhan/WIV02/2019
20 - BetaCoV/Nonthaburi/6 1/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
6 - BetaCoV/Wuhan/WIV02/2019
18 - BetaCoV/China/WHU02/2020
24 - BetaCoV/Nonthaburi/74/2020
16 - BetaCov/Wuhan/WH03/2020
6 - BetaCoV/Wuhan/WIV02/2019
16 - BetaCov/Wuhan/WH03/2020
4 - BetaCoV/Wuhan/IV DC-HB-05/2019
25 - BetaCoV/Shenzhen/SZTH-00 1/2020
23 - BetaCoV/Jiangxi/IV DC-JX-002/2020
26 - BetaCoV/Shenzhen/SZTH-002/2020
29 - BetaCoV/Guangdong/20SFO0 14/2020
12 - BetaCoV/Wuhan/IPBCAMS-WH-03/2019
15 - BetaCoV/Wuhan/IPBCAMS-WH-05/2020
25 - BetaCoV/Shenzhen/SZTH-00 1/2020
30 - BetaCoV/Guangdong/20SF025/2020
19 - BetaCov/Wuhan/WH04/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
9 - BetaCoV/Wuhan/WIV07/2019
25 - BetaCoV/Shenzhen/SZTH-00 1/2020
25 - BetaCoV/Shenzhen/SZTH-00 1/2020
6 - BetaCoV/Wuhan/WIV02/2019
8 - BetaCoV/Wuhan/WIV06/2019
16 - BetaCov/Wuhan/WH03/2020
38 - BetaCoV/Guangdong/20SF040/2020
9 - BetaCoV/Wuhan/WIV07/2019
41 - BetaCoV/USA/WA 1/2020
13 - BetaCoV/Wuhan/IPBCAMS-WH-02/2019
23 - BetaCoV/Jiangxi/IV DC-JX-002/2020
40 - BetaCoV/Beijing/IV DC-BJ-005/2020
44 - BetaCoV/Jiangsu/IVDC-JS-00 1/2020
18 - BetaCoV/China/WHU02/2020
7 - BetaCoV/Wuhan/WIV05/2019
16 - BetaCov/Wuhan/WH03/2020
19 - BetaCov/Wuhan/WH04/2020
36 - BetaCoV/Zhejiang/WZ-02/2020
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
49 - BetaCoV/USA/AZ1/2020
51 - BetaCoV/Guangzhou/20SF206/2020
34 - BetaCoV/Shenzhen/SZTH-004/2020
53 - BetaCo V/Foshan/20SF2 10/2020
6 - BetaCoV/Wuhan/WIV02/2019
43 - BetaCoV/Shandong/IVDC-SD-00 1/2020
49 - BetaCoV/USA/AZ1/2020
16 - BetaCov/Wuhan/WH03/2020
9 - BetaCoV/Wuhan/WIV07/2019
48 - BetaCoV/USA/CA2/2020
13 - BetaCoV/Wuhan/IPBCAMS-WH-02/2019
25 - BetaCoV/Shenzhen/SZTH-00 1/2020
6 - BetaCoV/Wuhan/WIV02/2019
16 - BetaCov/Wuhan/WH03/2020
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
10 - BetaCoV/Wuhan/HBCDC-HB-01/2019
32 - BetaCoV/Zhejiang/WZ-0 1/2020
60 - BetaCoV/Singapore/ 1/2020
32 - BetaCoV/Zhejiang/WZ-0 1/2020
40 - BetaCoV/Beijing/IV DC-BJ-005/2020

66
69
71
73
22
25
33
36
39
40
42
43
46
48
51
58
59
59
62
63
63
63
63
68
70
70
70
70
70
72
78
79
79
79
79
80
80
80
81
12
13
15
20
21
22
23
23
25
25
26
27
31
31
32
32
33
33
33
34
36
36
36
37
39
40
40
42
43
43
43
43
44
44
45
45
45
48
50
51
51
51
51
51
51
55
56
56
58
58
58
59
60
61
62
62
63
63
63
64
64
64
65
65

3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

-

BetaCoV/USA/WA1-A12/2020
BetaCoV/Germany/BavPat 1/2020
BetaCoV/England/01/2020
BetaCoV/Finland/1/2020
BetaCoV/Shenzhen/HKU-SZ-005/2020
BetaCoV/Shenzhen/SZTH-00 1/2020
BetaCoV/Shenzhen/SZTH-003/2020
BetaCoV/Zhejiang/WZ-02/2020
BetaCoV/Chongqing/IVDC-CQ-00 1/2020
BetaCoV/Beijing/IV DC-BJ-005/2020
BetaCoV/Hangzhou/HZCDC000 1/2020
BetaCoV/Shandong/IVDC-SD-00 1/2020
BetaCoV/USA/IL 1/2020
BetaCoV/USA/CA2/2020
BetaCoV/Guangzhou/20SF206/2020
BetaCo V/France/IDF0372/2020
BetaCoV/France/IDF0373/2020
BetaCoV/France/IDF0373/2020
BetaCoV/Australia/NS WO 1/2020
BetaCoV/Australia/VICO1/2020
BetaCoV/Australia/VICO1/2020
BetaCoV/Australia/VICO1/2020
BetaCoV/Australia/VICO1/2020
BetaCoV/Singapore/2/2020
BetaCoV/Australia/QLD0O1/2020
BetaCoV/Australia/QLD0O1/2020
BetaCoV/Australia/QLD0O1/2020
BetaCoV/Australia/QLD0O1/2020
BetaCoV/Australia/QLD0O1/2020
BetaCoV/England/02/2020
BetaCov/France/IDF0626/2020
BetaCoV/Australia/QLD02/2020
BetaCoV/Australia/QLD02/2020
BetaCoV/Australia/QLD02/2020
BetaCoV/Australia/QLD02/2020
BetaCoV/Taiwan/NTU01/2020
BetaCoV/Taiwan/NTU01/2020
BetaCoV/Taiwan/NTU01/2020
BetaCoV/Singapore/3/2020
BetaCoV/Wuhan/IPBCAMS-WH-03/2019
BetaCoV/Wuhan/IPBCAMS-WH-02/2019
BetaCoV/Wuhan/IPBCAMS-WH-05/2020
BetaCoV/Nonthaburi/6 1/2020
BetaCoV/Shenzhen/HKU-SZ-002/2020
BetaCoV/Shenzhen/HKU-SZ-005/2020
BetaCoV/Jiangxi/IV DC-JX-002/2020
BetaCoV/Jiangxi/IV DC-JX-002/2020
BetaCoV/Shenzhen/SZTH-00 1/2020
BetaCoV/Shenzhen/SZTH-00 1/2020
BetaCoV/Shenzhen/SZTH-002/2020
BetaCoV/Guangdong/20SFO0 12/2020
BetaCoV/Sichuan/ITVDC-SC-00 1/2020
BetaCoV/Sichuan/ITVDC-SC-00 1/2020
BetaCoV/Zhejiang/WZ-0 1/2020
BetaCoV/Zhejiang/WZ-0 1/2020
BetaCoV/Shenzhen/SZTH-003/2020
BetaCoV/Shenzhen/SZTH-003/2020
BetaCoV/Shenzhen/SZTH-003/2020
BetaCoV/Shenzhen/SZTH-004/2020
BetaCoV/Zhejiang/WZ-02/2020
BetaCoV/Zhejiang/WZ-02/2020
BetaCoV/Zhejiang/WZ-02/2020
BetaCoV/Yunnan/IVDC- Y N-003/2020
BetaCoV/Chongqing/IVDC-CQ-00 1/2020
BetaCoV/Beijing/IV DC-BJ-005/2020
BetaCoV/Beijing/IV DC-BJ-005/2020
BetaCoV/Hangzhou/HZCDC000 1/2020
BetaCoV/Shandong/IVDC-SD-00 1/2020
BetaCoV/Shandong/IVDC-SD-00 1/2020
BetaCoV/Shandong/IVDC-SD-00 1/2020
BetaCoV/Shandong/IVDC-SD-00 1/2020
BetaCoV/Jiangsu/IVDC-JS-00 1/2020
BetaCoV/Jiangsu/IVDC-JS-00 1/2020
BetaCoV/Zhejiang/Hangzhou- 1/2020
BetaCoV/Zhejiang/Hangzhou- 1/2020
BetaCoV/Zhejiang/Hangzhou- 1/2020
BetaCoV/USA/CA2/2020
BetaCoV/Guangdong/20SF174/2020
BetaCoV/Guangzhou/20SF206/2020
BetaCoV/Guangzhou/20SF206/2020
BetaCoV/Guangzhou/20SF206/2020
BetaCoV/Guangzhou/20SF206/2020
BetaCoV/Guangzhou/20SF206/2020
BetaCoV/Guangzhou/20SF206/2020
BetaCoV/Taiwan/2/2020
BetaCoV/USA/CA1/2020
BetaCoV/USA/CA1/2020
BetaCo V/France/IDF0372/2020
BetaCo V/France/IDF0372/2020
BetaCo V/France/IDF0372/2020
BetaCoV/France/IDF0373/2020
BetaCoV/Singapore/ 1/2020
BetaCoV/Chonggqing/ZX0 1/2020
BetaCoV/Australia/NS WO 1/2020
BetaCoV/Australia/NS WO 1/2020
BetaCoV/Australia/VICO1/2020
BetaCoV/Australia/VICO1/2020
BetaCoV/Australia/VICO1/2020
BetaCoV/Japan/AI/I-004/2020
BetaCoV/Japan/AI/I-004/2020
BetaCoV/Japan/AI/I-004/2020
BetaCoV/Korea/KCDC03/2020
BetaCoV/Korea/KCDC03/2020

18/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Table 9. Edge weight between distinct nucleotide sequences in the Transcendental
Information Cascade we constructed (contd.).
Source sequence

Target sequence

Edge weight

60 - BetaCoV/Singapore/ 1/2020
58 - BetaCo V/France/IDF0372/2020
62 - BetaCoV/Australia/NS WO 1/2020
18 - BetaCoV/China/WHU02/2020
36 - BetaCoV/Zhejiang/WZ-02/2020
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
2 - BetaCov/Wuhan/WHO01/2019
16 - BetaCov/Wuhan/WH03/2020
19 - BetaCov/Wuhan/WH04/2020
57 - BetaCoV/Guangdong/20SF201/2020
2 - BetaCov/Wuhan/WHO01/2019
7 - BetaCoV/Wuhan/WIV05/2019
8 - BetaCoV/Wuhan/WIV06/2019
33 - BetaCoV/Shenzhen/SZTH-003/2020
58 - BetaCo V/France/IDF0372/2020
61 - BetaCoV/Chonggqing/ZX0 1/2020
64 - BetaCoV/Japan/AI/I-004/2020
34 - BetaCoV/Shenzhen/SZTH-004/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
55 - BetaCoV/Taiwan/2/2020
19 - BetaCov/Wuhan/WH04/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
67 - BetaCoV/USA/W A 1-F6/2020
2 - BetaCov/Wuhan/WHO01/2019
57 - BetaCoV/Guangdong/20SF201/2020
19 - BetaCov/Wuhan/WH04/2020
58 - BetaCo V/France/IDF0372/2020
59 - BetaCoV/France/IDF0373/2020
61 - BetaCoV/Chonggqing/ZX0 1/2020
55 - BetaCoV/Taiwan/2/2020
14 - BetaCoV/Wuhan/IV DC-HB-04/2020
31 - BetaCoV/Sichuan/ITVDC-SC-00 1/2020
32 - BetaCoV/Zhejiang/WZ-0 1/2020
13 - BetaCoV/Wuhan/IPBCAMS-WH-02/2019
60 - BetaCoV/Singapore/ 1/2020

65
66
66
68
68
68
69
69
69
69
70
70
70
70
70
70
70
71
71
71
72
72
72
74
76
77
77
77
77
78
79
79
79
80
80

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

-

BetaCoV/Korea/KCDC03/2020
BetaCoV/USA/WA1-A12/2020
BetaCoV/USA/WA1-A12/2020
BetaCoV/Singapore/2/2020
BetaCoV/Singapore/2/2020
BetaCoV/Singapore/2/2020
BetaCoV/Germany/BavPat 1/2020
BetaCoV/Germany/BavPat 1/2020
BetaCoV/Germany/BavPat 1/2020
BetaCoV/Germany/BavPat 1/2020
BetaCoV/Australia/QLD0O1/2020
BetaCoV/Australia/QLD0O1/2020
BetaCoV/Australia/QLD0O1/2020
BetaCoV/Australia/QLD0O1/2020
BetaCoV/Australia/QLD0O1/2020
BetaCoV/Australia/QLD0O1/2020
BetaCoV/Australia/QLD0O1/2020
BetaCoV/England/01/2020
BetaCoV/England/01/2020
BetaCoV/England/01/2020
BetaCoV/England/02/2020
BetaCoV/England/02/2020
BetaCoV/England/02/2020
BetaCoV/USA/CA3/2020
BetaCoV/USA/CA5/2020
BetaCo V/France/IDF05 15/2020
BetaCo V/France/IDF05 15/2020
BetaCo V/France/IDF05 15/2020
BetaCo V/France/IDF05 15/2020
BetaCov/France/IDF0626/2020
BetaCoV/Australia/QLD02/2020
BetaCoV/Australia/QLD02/2020
BetaCoV/Australia/QLD02/2020
BetaCoV/Taiwan/NTU01/2020
BetaCoV/Taiwan/NTU01/2020

19/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Table 10. Frequency of edge distances.
Edge distance

Frequency

1
2
3
4
5
6
7
20
10
9
22
27
24
14
26
11
13
8
15
12
17
23
16
43
25
29
21
19
28
34
31
18
45
46
30
56
44
60
72
73
38
58
36
39
37
41
55
63
57
59
48
47
71
35
74
42
62
64
53
49
40
33
54
65
61
70
32
78
77
79
75
51
50
67
52
68

801289
197353
166842
123821
92366
88539
87805
55715
51884
32851
27681
26443
24707
11886
7172
7013
6058
5205
3772
3304
3124
2893
2240
2168
2044
1968
1892
1811
1807
1682
1623
1601
1511
1445
1422
1402
1363
1344
1256
1176
1172
1159
1125
1071
1030
1011
961
911
899
836
832
732
713
685
617
616
529
505
477
474
468
459
405
401
363
358
351
342
323
284
265
4
2
2
1
1

20/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Table 11. Cluster memberships of the nucleotide sequences (full TIC network).
Sequence ID

In-degree

Out-degree

Degree

Cluster

2 - BetaCov/Wuhan/WHO01/2019
6 - BetaCoV/Wuhan/WIV02/2019
7 - BetaCoV/Wuhan/WIV05/2019
8 - BetaCoV/Wuhan/WIV06/2019
9 - BetaCoV/Wuhan/WIV07/2019
16 - BetaCov/Wuhan/WH03/2020
19 - BetaCov/Wuhan/WH04/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
32 - BetaCoV/Zhejiang/WZ-0 1/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
34 - BetaCoV/Shenzhen/SZTH-004/2020
36 - BetaCoV/Zhejiang/WZ-02/2020
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
55 - BetaCoV/Taiwan/2/2020
59 - BetaCoV/France/IDF0373/2020
62 - BetaCoV/Australia/NS WO 1/2020
64 - BetaCoV/Japan/AI/I-004/2020
65 - BetaCoV/Korea/KCDC03/2020
69 - BetaCoV/Germany/BavPat 1/2020
70 - BetaCoV/Australia/QLD0O1/2020
79 - BetaCoV/Australia/QLD02/2020
80 - BetaCoV/Taiwan/NTU01/2020
81 - BetaCoV/Singapore/3/2020
1 - BetaCoV/Wuhan/IPBCAMS-WH-01/2019
3 - BetaCoV/Wuhan/IV DC-HB-01/2019
4 - BetaCoV/Wuhan/IV DC-HB-05/2019
5 - BetaCoV/Wuhan/WIV04/2019
11 - BetaCoV/Wuhan/IPBCAMS-WH-04/2019
12 - BetaCoV/Wuhan/IPBCAMS-WH-03/2019
13 - BetaCoV/Wuhan/IPBCAMS-WH-02/2019
14 - BetaCoV/Wuhan/IV DC-HB-04/2020
15 - BetaCoV/Wuhan/IPBCAMS-WH-05/2020
10 - BetaCoV/Wuhan/HBCDC-HB-01/2019
20 - BetaCoV/Nonthaburi/6 1/2020
24 - BetaCoV/Nonthaburi/74/2020
27 - BetaCoV/Guangdong/20SFO0 12/2020
28 - BetaCoV/Guangdong/20SFO0 13/2020
29 - BetaCoV/Guangdong/20SFO0 14/2020
30 - BetaCoV/Guangdong/20SF025/2020
35 - BetaCoV/Guangdong/20SF028/2020
38 - BetaCoV/Guangdong/20SF040/2020
58 - BetaCo V/France/IDF0372/2020
78 - BetaCov/France/IDF0626/2020
22 - BetaCoV/Shenzhen/HKU-SZ-005/2020
23 - BetaCoV/Jiangxi/IV DC-JX-002/2020
25 - BetaCoV/Shenzhen/SZTH-00 1/2020
26 - BetaCoV/Shenzhen/SZTH-002/2020
31 - BetaCoV/Sichuan/ITVDC-SC-00 1/2020
37 - BetaCoV/Yunnan/IVDC- Y N-003/2020
39 - BetaCoV/Chongqing/IVDC-CQ-00 1/2020
41 - BetaCoV/USA/WA 1/2020
43 - BetaCoV/Shandong/IVDC-SD-00 1/2020
46 - BetaCoV/USA/IL 1/2020
17 - BetaCoV/China/WHU01/2020
18 - BetaCoV/China/WHU02/2020
40 - BetaCoV/Beijing/IV DC-BJ-005/2020
44 - BetaCoV/Jiangsu/IVDC-JS-00 1/2020
68 - BetaCoV/Singapore/2/2020
77 - BetaCo V/France/IDF05 15/2020
47 - BetaCoV/Chonggqing/Y C0 1/2020
48 - BetaCoV/USA/CA2/2020
49 - BetaCoV/USA/AZ1/2020
56 - BetaCoV/USA/CA1/2020
60 - BetaCoV/Singapore/ 1/2020
61 - BetaCoV/Chonggqing/ZX0 1/2020
50 - BetaCoV/Guangdong/20SF174/2020
51 - BetaCoV/Guangzhou/20SF206/2020
52 - BetaCo V/Foshan/20SF207/2020
53 - BetaCo V/Foshan/20SF2 10/2020
54 - BetaCoV/Foshan/20SF21 1/2020
57 - BetaCoV/Guangdong/20SF201/2020
63 - BetaCoV/Australia/VICO1/2020
66 - BetaCoV/USA/WA1-A12/2020
67 - BetaCoV/USA/W A 1-F6/2020
71 - BetaCoV/England/01/2020
72 - BetaCoV/England/02/2020
73 - BetaCoV/Finland/1/2020
74 - BetaCoV/USA/CA3/2020
75 - BetaCoV/USA/CA4/2020
76 - BetaCoV/USA/CA5/2020
82 - BetaCoV/Belgium/GHB-0302 1/2020

1
2
3
4
5
7
9
11
13
18
14
18
17
19
21
15
24
24
25
10
16
30
29
26
0
2
1
2
6
3
3
2
3
6
6
3
3
1
2
2
6
3
14
12
9
4
7
4
5
8
5
5
9
5
8
1
13
7
16
9
20
5
6
7
7
8
19
10
2
2
1
5
20
9
1
8
5
4
4
1
3
8

34
30
26
26
25
28
27
21
15
20
21
20
18
17
16
12
6
9
6
7
6
3
2
1
3
2
2
7
2
4
6
4
8
6
4
5
1
2
3
7
3
11
12
4
5
7
9
7
9
3
3
6
8
3
1
14
11
12
5
5
9
6
7
8
7
12
2
3
3
3
3
14
9
1
8
2
3
2
1
2
6
0

35
32
29
30
30
35
36
32
28
38
35
38
35
36
37
27
30
33
31
17
22
33
31
27
3
4
3
9
8
7
9
6
11
12
10
8
4
3
5
9
9
14
26
16
14
11
16
11
14
11
8
11
17
8
9
15
24
19
21
14
29
11
13
15
14
20
21
13
5
5
4
19
29
10
9
10
8
6
5
3
9
8

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
5
5
5
5
5
5
6
6
6
6
6
6
7
7
7
7
7
7
7
7
7
7

21/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Table 12. Inter-cluster similarities for the full TIC network.
Inter-cluster pair

Avg. similarity

SD

Min. similarity

Max. similarity

0-1
0-2
0-3
0-4
0-5
0-6
0-7
1-2
1-3
1-4
1-5
1-6
1-7
2-3
2-4
2-5
2-6
2-7
3-4
3-5
3-6
3-7
4-5
4-6
4-7
5-6
5-7
6-7

0.267773
0.265648
0.267719
0.267501
0.267639
0.265093
0.267556
0.259499
0.999513
0.269435
0.927233
0.258528
0.998823
0.259472
0.255754
0.260785
0.284333
0.259330
0.269369
0.926970
0.258482
0.998632
0.268894
0.263907
0.269143
0.260599
0.926460
0.258383

0.013962
0.012247
0.013965
0.021119
0.013011
0.013211
0.013985
0.000047
0.000290
0.000147
0.103628
0.000033
0.001846
0.000053
0.000079
0.001855
0.000043
0.000421
0.000184
0.103499
0.000049
0.001816
0.000682
0.000187
0.000600
0.002943
0.103206
0.000525

0.252325
0.251072
0.252326
0.250904
0.252337
0.251181
0.250745
0.259407
0.998796
0.269120
0.781755
0.258454
0.993938
0.259373
0.255587
0.259407
0.284259
0.258067
0.268965
0.781540
0.258387
0.993235
0.267715
0.263414
0.267290
0.258521
0.779396
0.256844

0.293298
0.288222
0.293298
0.358635
0.293264
0.288327
0.293466
0.259605
0.999900
0.269655
0.999966
0.258598
0.999933
0.259572
0.255887
0.263405
0.284454
0.259682
0.269823
0.999967
0.258598
1.000000
0.269603
0.264057
0.269928
0.264821
0.999900
0.258889

53 - BetaCo V/Foshan/20SF2 10/2020
4 - BetaCoV/Wuhan/IV DC-HB-05/2019

3 - BetaCoV/Wuhan/IV DC-HB-01/2019

52 - BetaCo V/Foshan/20SF207/2020
75 - BetaCoV/USA/CA4/2020

27 - BetaCoV/Guangdong/20SFO0 12/2020
1 - BetaCoV/Wuhan/IPBCAMS-WH-01/2019

54 - BetaCoV/Foshan/20SF21 1/2020

82 - BetaCoV/Belgium/GHB-0302 1/2020
77 - BetaCo V/France/IDF05 15/2020
51 - BetaCoV/Guangzhou/20SF206/2020
28 - BetaCoV/Guangdong/20SFO0 13/2020
56 - BetaCoV/USA/CA1/2020
57 - BetaCoV/Guangdong/20SF201/2020

60 - BetaCoV/Singapore/ 1/2020
46 - BetaCoV/USA/IL 1/2020

66 - BetaCoV/USA/WA1-A12/2020
78 - BetaCov/France/IDF0626/2020

61 - BetaCoV/Chonggqing/ZX0 1/2020

48 - BetaCoV/USA/CA2/2020
74 - BetaCoV/USA/CA3/2020

69 - BetaCoV/Germany/BavPat 1/2020
49 - BetaCoV/USA/AZ1/2020
76 - BetaCoV/USA/CA5/2020

12 - BetaCoV/Wuhan/IPBCAMS-WH-03/2019
14 - BetaCoV/Wuhan/IV DC-HB-04/2020

58 - BetaCo V/France/IDF0372/2020
80 - BetaCoV/Taiwan/NTU01/2020

5 - BetaCoV/Wuhan/WIV04/2019
79 - BetaCoV/Australia/QLD02/2020

70 - BetaCoV/Australia/QLD0O1/2020
59 - BetaCoV/France/IDF0373/2020

81 - BetaCoV/Singapore/3/2020
64 - BetaCoV/Japan/AI/I-004/2020
63 - BetaCoV/Australia/VICO1/2020
67 - BetaCoV/USA/W A 1-F6/2020

55 - BetaCoV/Taiwan/2/2020
65 - BetaCoV/Korea/KCDC03/2020
62 - BetaCoV/Australia/NS WO 1/2020

2 - BetaCov/Wuhan/WHO01/2019

68 - BetaCoV/Singapore/2/2020

47 - BetaCoV/Chonggqing/Y C0 1/2020

43 - BetaCoV/Shandong/IVDC-SD-00 1/2020

50 - BetaCoV/Guangdong/20SF174/2020

8 - BetaCoV/Wuhan/WIV06/2019
44 - BetaCoV/Jiangsu/IVDC-JS-00 1/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020

7 - BetaCoV/Wuhan/WIV05/2019
9 - BetaCoV/Wuhan/WIV07/2019

73 - BetaCoV/Finland/1/2020

34 - BetaCoV/Shenzhen/SZTH-004/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
41 - BetaCoV/USA/WA 1/2020
6 - BetaCoV/Wuhan/WIV02/2019

24 - BetaCoV/Nonthaburi/74/2020
30 - BetaCoV/Guangdong/20SF025/2020

19 - BetaCov/Wuhan/WH04/2020

13 - BetaCoV/Wuhan/IPBCAMS-WH-02/2019
16 - BetaCov/Wuhan/WH03/2020

36 - BetaCoV/Zhejiang/WZ-02/2020
71 - BetaCoV/England/01/2020

21 - BetaCoV/Shenzhen/HKU-SZ-002/2020

26 - BetaCoV/Shenzhen/SZTH-002/2020

37 - BetaCoV/Yunnan/IVDC- Y N-003/2020
40 - BetaCoV/Beijing/IV DC-BJ-005/2020

11 - BetaCoV/Wuhan/IPBCAMS-WH-04/2019
32 - BetaCoV/Zhejiang/WZ-0 1/2020
29 - BetaCoV/Guangdong/20SFO0 14/2020

22 - BetaCoV/Shenzhen/HKU-SZ-005/2020

72 - BetaCoV/England/02/2020

38 - BetaCoV/Guangdong/20SF040/2020
10 - BetaCoV/Wuhan/HBCDC-HB-01/2019

31 - BetaCoV/Sichuan/ITVDC-SC-00 1/2020

23 - BetaCoV/Jiangxi/IV DC-JX-002/2020
15 - BetaCoV/Wuhan/IPBCAMS-WH-05/2020
39 - BetaCoV/Chongqing/IVDC-CQ-00 1/2020
25 - BetaCoV/Shenzhen/SZTH-00 1/2020

18 - BetaCoV/China/WHU02/2020

17 - BetaCoV/China/WHU01/2020
35 - BetaCoV/Guangdong/20SF028/2020

20 - BetaCoV/Nonthaburi/6 1/2020

Figure 6. +1 reading frame network.

22/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Table 13. Cluster memberships of the nucleotide sequences (network for +1 reading
frames).
Sequence ID

In-degree

Out-degree

Degree

Cluster

2 - BetaCov/Wuhan/WHO01/2019
6 - BetaCoV/Wuhan/WIV02/2019
7 - BetaCoV/Wuhan/WIV05/2019
8 - BetaCoV/Wuhan/WIV06/2019
9 - BetaCoV/Wuhan/WIV07/2019
16 - BetaCov/Wuhan/WH03/2020
19 - BetaCov/Wuhan/WH04/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
32 - BetaCoV/Zhejiang/WZ-0 1/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
34 - BetaCoV/Shenzhen/SZTH-004/2020
36 - BetaCoV/Zhejiang/WZ-02/2020
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
55 - BetaCoV/Taiwan/2/2020
59 - BetaCoV/France/IDF0373/2020
62 - BetaCoV/Australia/NS WO 1/2020
64 - BetaCoV/Japan/AI/I-004/2020
65 - BetaCoV/Korea/KCDC03/2020
69 - BetaCoV/Germany/BavPat 1/2020
70 - BetaCoV/Australia/QLD0O1/2020
79 - BetaCoV/Australia/QLD02/2020
80 - BetaCoV/Taiwan/NTU01/2020
81 - BetaCoV/Singapore/3/2020
1 - BetaCoV/Wuhan/IPBCAMS-WH-01/2019
3 - BetaCoV/Wuhan/IV DC-HB-01/2019
4 - BetaCoV/Wuhan/IV DC-HB-05/2019
5 - BetaCoV/Wuhan/WIV04/2019
11 - BetaCoV/Wuhan/IPBCAMS-WH-04/2019
12 - BetaCoV/Wuhan/IPBCAMS-WH-03/2019
13 - BetaCoV/Wuhan/IPBCAMS-WH-02/2019
14 - BetaCoV/Wuhan/IV DC-HB-04/2020
15 - BetaCoV/Wuhan/IPBCAMS-WH-05/2020
17 - BetaCoV/China/WHU01/2020
18 - BetaCoV/China/WHU02/2020
40 - BetaCoV/Beijing/IV DC-BJ-005/2020
44 - BetaCoV/Jiangsu/IVDC-JS-00 1/2020
68 - BetaCoV/Singapore/2/2020
77 - BetaCo V/France/IDF05 15/2020
22 - BetaCoV/Shenzhen/HKU-SZ-005/2020
23 - BetaCoV/Jiangxi/IV DC-JX-002/2020
25 - BetaCoV/Shenzhen/SZTH-00 1/2020
26 - BetaCoV/Shenzhen/SZTH-002/2020
31 - BetaCoV/Sichuan/ITVDC-SC-00 1/2020
37 - BetaCoV/Yunnan/IVDC- Y N-003/2020
39 - BetaCoV/Chongqing/IVDC-CQ-00 1/2020
41 - BetaCoV/USA/WA 1/2020
43 - BetaCoV/Shandong/IVDC-SD-00 1/2020
46 - BetaCoV/USA/IL 1/2020
10 - BetaCoV/Wuhan/HBCDC-HB-01/2019
20 - BetaCoV/Nonthaburi/6 1/2020
24 - BetaCoV/Nonthaburi/74/2020
27 - BetaCoV/Guangdong/20SFO0 12/2020
28 - BetaCoV/Guangdong/20SFO0 13/2020
29 - BetaCoV/Guangdong/20SFO0 14/2020
30 - BetaCoV/Guangdong/20SF025/2020
35 - BetaCoV/Guangdong/20SF028/2020
38 - BetaCoV/Guangdong/20SF040/2020
58 - BetaCo V/France/IDF0372/2020
78 - BetaCov/France/IDF0626/2020
50 - BetaCoV/Guangdong/20SF174/2020
51 - BetaCoV/Guangzhou/20SF206/2020
52 - BetaCo V/Foshan/20SF207/2020
53 - BetaCo V/Foshan/20SF2 10/2020
54 - BetaCoV/Foshan/20SF21 1/2020
57 - BetaCoV/Guangdong/20SF201/2020
47 - BetaCoV/Chonggqing/Y C0 1/2020
48 - BetaCoV/USA/CA2/2020
49 - BetaCoV/USA/AZ1/2020
56 - BetaCoV/USA/CA1/2020
60 - BetaCoV/Singapore/ 1/2020
61 - BetaCoV/Chonggqing/ZX0 1/2020
63 - BetaCoV/Australia/VICO1/2020
66 - BetaCoV/USA/WA1-A12/2020
67 - BetaCoV/USA/W A 1-F6/2020
71 - BetaCoV/England/01/2020
72 - BetaCoV/England/02/2020
73 - BetaCoV/Finland/1/2020
74 - BetaCoV/USA/CA3/2020
75 - BetaCoV/USA/CA4/2020
76 - BetaCoV/USA/CA5/2020
82 - BetaCoV/Belgium/GHB-0302 1/2020

1
2
3
4
5
7
9
11
11
15
13
16
16
17
20
13
22
22
24
6
9
27
26
26
0
2
1
2
6
2
2
2
2
8
1
10
4
14
5
8
2
4
4
3
7
4
5
7
5
6
5
3
2
1
2
2
6
3
11
11
18
5
2
2
1
5
19
5
6
6
6
8
12
8
1
7
3
4
3
1
2
8

27
25
24
24
21
23
21
19
12
19
20
18
15
15
14
10
6
9
5
7
6
3
2
1
3
2
1
6
2
3
4
4
7
1
11
9
12
5
5
5
5
5
6
8
3
3
5
6
3
5
3
5
1
2
2
6
3
9
8
4
2
2
3
3
3
12
9
6
6
8
6
10
7
1
7
2
3
2
1
2
6
0

28
27
27
28
26
30
30
30
23
34
33
34
31
32
34
23
28
31
29
13
15
30
28
27
3
4
2
8
8
5
6
6
9
9
12
19
16
19
10
13
7
9
10
11
10
7
10
13
8
11
8
8
3
3
4
8
9
12
19
15
20
7
5
5
4
17
28
11
12
14
12
18
19
9
8
9
6
6
4
3
8
8

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
4
5
5
5
5
5
5
6
6
6
6
6
6
7
7
7
7
7
7
7
7
7
7

Table 14. Intra-cluster similarities (network for +1 reading frames).
Cluster

Avg. similarity

SD

Min. similarity

Max. similarity

Cluster size

0
1
2
3
4
5
6
7

0.277353
0.999730
0.998768
0.999385
0.999915
0.999926
0.883701
0.997900

0.088247
0.000222
0.001345
0.000371
0.000048
0.000036
0.112398
0.002419

0.250620
0.999231
0.996387
0.998461
0.999832
0.999866
0.781976
0.991158

0.999866
1.000000
1.000000
0.999933
1.000000
1.000000
0.999899
1.000000

24
9
6
10
11
6
6
10

23/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

28 - BetaCoV/Guangdong/20SFO0 13/2020

66 - BetaCoV/USA/WA1-A12/2020

30 - BetaCoV/Guangdong/20SF025/2020
48 - BetaCoV/USA/CA2/2020
60 - BetaCoV/Singapore/ 1/2020

72 - BetaCoV/England/02/2020
67 - BetaCoV/USA/W A 1-F6/2020

35 - BetaCoV/Guangdong/20SF028/2020

56 - BetaCoV/USA/CA1/2020

74 - BetaCoV/USA/CA3/2020

29 - BetaCoV/Guangdong/20SFO0 14/2020

54 - BetaCoV/Foshan/20SF21 1/2020

43 - BetaCoV/Shandong/IVDC-SD-00 1/2020
58 - BetaCo V/France/IDF0372/2020
38 - BetaCoV/Guangdong/20SF040/2020
68 - BetaCoV/Singapore/2/2020
31 - BetaCoV/Sichuan/ITVDC-SC-00 1/2020
41 - BetaCoV/USA/WA 1/2020

44 - BetaCoV/Jiangsu/IVDC-JS-00 1/2020

61 - BetaCoV/Chonggqing/ZX0 1/2020
63 - BetaCoV/Australia/VICO1/2020

73 - BetaCoV/Finland/1/2020

71 - BetaCoV/England/01/2020
62 - BetaCoV/Australia/NS WO 1/2020
57 - BetaCoV/Guangdong/20SF201/2020

27 - BetaCoV/Guangdong/20SFO0 12/2020

49 - BetaCoV/USA/AZ1/2020

59 - BetaCoV/France/IDF0373/2020
39 - BetaCoV/Chongqing/IVDC-CQ-00
1/2020
47 - BetaCoV/Chonggqing/Y C0 1/2020
69 - BetaCoV/Germany/BavPat 1/2020
40 - BetaCoV/Beijing/IV DC-BJ-005/2020
37 - BetaCoV/Yunnan/IVDC- Y N-003/2020

65 - BetaCoV/Korea/KCDC03/2020

55 - BetaCoV/Taiwan/2/2020
34 - BetaCoV/Shenzhen/SZTH-004/2020
42 - BetaCoV/Hangzhou/HZCDC000
1/2020
32 - BetaCoV/Zhejiang/WZ-0
1/2020

24 - BetaCoV/Nonthaburi/74/2020
64 - BetaCoV/Japan/AI/I-004/2020

45 - BetaCoV/Zhejiang/Hangzhou- 1/2020

70 - BetaCoV/Australia/QLD0O1/202036 - BetaCoV/Zhejiang/WZ-02/2020

52 - BetaCo V/Foshan/20SF207/2020

33 - BetaCoV/Shenzhen/SZTH-003/2020

23 - BetaCoV/Jiangxi/IV DC-JX-002/2020
10 - BetaCoV/Wuhan/HBCDC-HB-01/2019

20 - BetaCoV/Nonthaburi/6 1/2020
50 - BetaCoV/Guangdong/20SF174/2020
2 - BetaCov/Wuhan/WHO01/2019
26 - BetaCoV/Shenzhen/SZTH-002/2020
3 - BetaCoV/Wuhan/IV DC-HB-01/2019

79 - BetaCoV/Australia/QLD02/2020
81 - BetaCoV/Singapore/3/2020
77 - BetaCo V/France/IDF05 15/2020

6 - BetaCoV/Wuhan/WIV02/2019
19 - BetaCov/Wuhan/WH04/2020

80 - BetaCoV/Taiwan/NTU01/2020

46 - BetaCoV/USA/IL 1/2020
78 - BetaCov/France/IDF0626/2020

82 - BetaCoV/Belgium/GHB-0302 1/2020

9 - BetaCoV/Wuhan/WIV07/2019
16 - BetaCov/Wuhan/WH03/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020

18 - BetaCoV/China/WHU02/2020
7 - BetaCoV/Wuhan/WIV05/2019
8 - BetaCoV/Wuhan/WIV06/2019

25 - BetaCoV/Shenzhen/SZTH-00 1/2020
51 - BetaCoV/Guangzhou/20SF206/2020

17 - BetaCoV/China/WHU01/2020

53 - BetaCo V/Foshan/20SF2 10/2020
13 - BetaCoV/Wuhan/IPBCAMS-WH-02/2019

22 - BetaCoV/Shenzhen/HKU-SZ-005/2020
4 - BetaCoV/Wuhan/IV DC-HB-05/2019
11 - BetaCoV/Wuhan/IPBCAMS-WH-04/2019
75 - BetaCoV/USA/CA4/2020
76 - BetaCoV/USA/CA5/2020

5 - BetaCoV/Wuhan/WIV04/2019

12 - BetaCoV/Wuhan/IPBCAMS-WH-03/2019
15 - BetaCoV/Wuhan/IPBCAMS-WH-05/2020

1 - BetaCoV/Wuhan/IPBCAMS-WH-01/2019
14 - BetaCoV/Wuhan/IV DC-HB-04/2020

Figure 7. +2 reading frame network.

24/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Table 15. Cluster memberships of the nucleotide sequences (network for +2 reading
frames).
Sequence ID

In-degree

Out-degree

Degree

Cluster

2 - BetaCov/Wuhan/WHO01/2019
6 - BetaCoV/Wuhan/WIV02/2019
7 - BetaCoV/Wuhan/WIV05/2019
8 - BetaCoV/Wuhan/WIV06/2019
9 - BetaCoV/Wuhan/WIV07/2019
16 - BetaCov/Wuhan/WH03/2020
19 - BetaCov/Wuhan/WH04/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
32 - BetaCoV/Zhejiang/WZ-0 1/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
34 - BetaCoV/Shenzhen/SZTH-004/2020
36 - BetaCoV/Zhejiang/WZ-02/2020
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
55 - BetaCoV/Taiwan/2/2020
59 - BetaCoV/France/IDF0373/2020
62 - BetaCoV/Australia/NS WO 1/2020
64 - BetaCoV/Japan/AI/I-004/2020
65 - BetaCoV/Korea/KCDC03/2020
69 - BetaCoV/Germany/BavPat 1/2020
70 - BetaCoV/Australia/QLD0O1/2020
79 - BetaCoV/Australia/QLD02/2020
80 - BetaCoV/Taiwan/NTU01/2020
81 - BetaCoV/Singapore/3/2020
1 - BetaCoV/Wuhan/IPBCAMS-WH-01/2019
3 - BetaCoV/Wuhan/IV DC-HB-01/2019
4 - BetaCoV/Wuhan/IV DC-HB-05/2019
5 - BetaCoV/Wuhan/WIV04/2019
11 - BetaCoV/Wuhan/IPBCAMS-WH-04/2019
12 - BetaCoV/Wuhan/IPBCAMS-WH-03/2019
13 - BetaCoV/Wuhan/IPBCAMS-WH-02/2019
14 - BetaCoV/Wuhan/IV DC-HB-04/2020
15 - BetaCoV/Wuhan/IPBCAMS-WH-05/2020
17 - BetaCoV/China/WHU01/2020
18 - BetaCoV/China/WHU02/2020
40 - BetaCoV/Beijing/IV DC-BJ-005/2020
44 - BetaCoV/Jiangsu/IVDC-JS-00 1/2020
68 - BetaCoV/Singapore/2/2020
77 - BetaCo V/France/IDF05 15/2020
10 - BetaCoV/Wuhan/HBCDC-HB-01/2019
20 - BetaCoV/Nonthaburi/6 1/2020
24 - BetaCoV/Nonthaburi/74/2020
27 - BetaCoV/Guangdong/20SFO0 12/2020
28 - BetaCoV/Guangdong/20SFO0 13/2020
29 - BetaCoV/Guangdong/20SFO0 14/2020
30 - BetaCoV/Guangdong/20SF025/2020
35 - BetaCoV/Guangdong/20SF028/2020
38 - BetaCoV/Guangdong/20SF040/2020
58 - BetaCo V/France/IDF0372/2020
78 - BetaCov/France/IDF0626/2020
22 - BetaCoV/Shenzhen/HKU-SZ-005/2020
23 - BetaCoV/Jiangxi/IV DC-JX-002/2020
25 - BetaCoV/Shenzhen/SZTH-00 1/2020
26 - BetaCoV/Shenzhen/SZTH-002/2020
31 - BetaCoV/Sichuan/ITVDC-SC-00 1/2020
37 - BetaCoV/Yunnan/IVDC- Y N-003/2020
39 - BetaCoV/Chongqing/IVDC-CQ-00 1/2020
41 - BetaCoV/USA/WA 1/2020
43 - BetaCoV/Shandong/IVDC-SD-00 1/2020
46 - BetaCoV/USA/IL 1/2020
50 - BetaCoV/Guangdong/20SF174/2020
51 - BetaCoV/Guangzhou/20SF206/2020
52 - BetaCo V/Foshan/20SF207/2020
53 - BetaCo V/Foshan/20SF2 10/2020
54 - BetaCoV/Foshan/20SF21 1/2020
57 - BetaCoV/Guangdong/20SF201/2020
47 - BetaCoV/Chonggqing/Y C0 1/2020
48 - BetaCoV/USA/CA2/2020
49 - BetaCoV/USA/AZ1/2020
56 - BetaCoV/USA/CA1/2020
60 - BetaCoV/Singapore/ 1/2020
61 - BetaCoV/Chonggqing/ZX0 1/2020
63 - BetaCoV/Australia/VICO1/2020
66 - BetaCoV/USA/WA1-A12/2020
67 - BetaCoV/USA/W A 1-F6/2020
71 - BetaCoV/England/01/2020
72 - BetaCoV/England/02/2020
73 - BetaCoV/Finland/1/2020
74 - BetaCoV/USA/CA3/2020
75 - BetaCoV/USA/CA4/2020
76 - BetaCoV/USA/CA5/2020
82 - BetaCoV/Belgium/GHB-0302 1/2020

1
2
3
4
5
7
9
10
11
16
14
14
16
16
21
14
22
22
23
6
10
28
27
26
0
2
1
2
6
2
2
2
2
8
1
12
6
14
7
6
6
3
3
1
2
2
6
3
12
11
8
4
7
3
4
8
4
5
6
5
19
7
2
2
1
5
20
4
6
6
6
7
15
7
1
6
2
4
4
1
2
8

31
28
24
22
23
23
25
20
14
19
20
19
18
16
15
12
5
8
6
7
6
3
2
1
3
2
1
6
2
3
3
3
7
1
13
9
11
4
5
6
4
4
1
2
3
6
3
10
9
4
4
5
5
6
9
3
3
5
7
3
2
3
2
2
3
12
9
4
5
7
5
10
7
1
8
2
3
2
1
2
6
0

32
30
27
26
28
30
34
30
25
35
34
33
34
32
36
26
27
30
29
13
16
31
29
27
3
4
2
8
8
5
5
5
9
9
14
21
17
18
12
12
10
7
4
3
5
8
9
13
21
15
12
9
12
9
13
11
7
10
13
8
21
10
4
4
4
17
29
8
11
13
11
17
22
8
9
8
5
6
5
3
8
8

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
5
5
5
5
5
5
6
6
6
6
6
6
7
7
7
7
7
7
7
7
7
7

Table 16. Intra-cluster similarities (network for +2 reading frames).
Cluster

Avg. similarity

SD

Min. similarity

Max. similarity

Cluster size

0
1
2
3
4
5
6
7

0.277353
0.999730
0.998768
0.999915
0.999385
0.999926
0.883701
0.997900

0.088247
0.000222
0.001345
0.000048
0.000371
0.000036
0.112398
0.002419

0.250620
0.999231
0.996387
0.999832
0.998461
0.999866
0.781976
0.991158

0.999866
1.000000
1.000000
1.000000
0.999933
1.000000
0.999899
1.000000

24
9
6
11
10
6
6
10

25/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

4 - BetaCoV/Wuhan/IV DC-HB-05/2019

3 - BetaCoV/Wuhan/IV DC-HB-01/2019

46 - BetaCoV/USA/IL 1/2020

51 - BetaCoV/Guangzhou/20SF206/2020
52 - BetaCo V/Foshan/20SF207/2020

53 - BetaCo V/Foshan/20SF2 10/2020

48 - BetaCoV/USA/CA2/2020

41 - BetaCoV/USA/WA 1/2020

74 - BetaCoV/USA/CA3/2020

18 - BetaCoV/China/WHU02/2020

5 - BetaCoV/Wuhan/WIV04/2019
50 - BetaCoV/Guangdong/20SF174/2020

43 - BetaCoV/Shandong/IVDC-SD-00 1/2020

44 - BetaCoV/Jiangsu/IVDC-JS-00 1/2020
10 - BetaCoV/Wuhan/HBCDC-HB-01/2019

75 - BetaCoV/USA/CA4/2020
47 - BetaCoV/Chonggqing/Y C0 1/2020
40 - BetaCoV/Beijing/IV DC-BJ-005/2020
49 - BetaCoV/USA/AZ1/2020
42 - BetaCoV/Hangzhou/HZCDC000
1/2020
7 - BetaCoV/Wuhan/WIV05/2019
32 - BetaCoV/Zhejiang/WZ-0 1/2020 37 - BetaCoV/Yunnan/IVDC- Y N-003/2020

20 - BetaCoV/Nonthaburi/6 1/2020
2 - BetaCov/Wuhan/WHO01/2019

45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
6 - BetaCoV/Wuhan/WIV02/2019
34 - BetaCoV/Shenzhen/SZTH-004/2020

26 - BetaCoV/Shenzhen/SZTH-002/2020

19 - BetaCov/Wuhan/WH04/2020
9 - BetaCoV/Wuhan/WIV07/2019
16 - BetaCov/Wuhan/WH03/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
57 - BetaCoV/Guangdong/20SF201/2020

1 - BetaCoV/Wuhan/IPBCAMS-WH-01/2019

36 - BetaCoV/Zhejiang/WZ-02/2020
80 - BetaCoV/Taiwan/NTU01/2020
55 - BetaCoV/Taiwan/2/2020

72 - BetaCoV/England/02/2020

17 - BetaCoV/China/WHU01/2020

8 - BetaCoV/Wuhan/WIV06/2019
38 - BetaCoV/Guangdong/20SF040/2020
35 - BetaCoV/Guangdong/20SF028/2020

65 - BetaCoV/Korea/KCDC03/2020

22 - BetaCoV/Shenzhen/HKU-SZ-005/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020 60 - BetaCoV/Singapore/ 1/2020
59 - BetaCoV/France/IDF0373/2020

73 - BetaCoV/Finland/1/2020

62 - BetaCoV/Australia/NS WO 1/2020
64 - BetaCoV/Japan/AI/I-004/2020
68 - BetaCoV/Singapore/2/2020
79 - BetaCoV/Australia/QLD02/2020
63 - BetaCoV/Australia/VICO1/2020

76 - BetaCoV/USA/CA5/2020

31 - BetaCoV/Sichuan/ITVDC-SC-00 1/2020

81 - BetaCoV/Singapore/3/2020
54 - BetaCoV/Foshan/20SF21 1/2020
67 - BetaCoV/USA/W A 1-F6/2020
27 - BetaCoV/Guangdong/20SFO0 12/2020

11 - BetaCoV/Wuhan/IPBCAMS-WH-04/2019
70 - BetaCoV/Australia/QLD0O1/2020

58 - BetaCo V/France/IDF0372/2020
39 - BetaCoV/Chongqing/IVDC-CQ-00 1/2020
61 - BetaCoV/Chonggqing/ZX0 1/2020

66 - BetaCoV/USA/WA1-A12/2020
23 - BetaCoV/Jiangxi/IV DC-JX-002/2020
56 - BetaCoV/USA/CA1/2020
15 - BetaCoV/Wuhan/IPBCAMS-WH-05/2020
69 - BetaCoV/Germany/BavPat 1/2020
82 - BetaCoV/Belgium/GHB-0302 1/2020
71 - BetaCoV/England/01/2020

25 - BetaCoV/Shenzhen/SZTH-00 1/2020

78 - BetaCov/France/IDF0626/2020

12 - BetaCoV/Wuhan/IPBCAMS-WH-03/2019

24 - BetaCoV/Nonthaburi/74/2020
30 - BetaCoV/Guangdong/20SF025/2020

77 - BetaCo V/France/IDF05 15/2020

13 - BetaCoV/Wuhan/IPBCAMS-WH-02/2019

29 - BetaCoV/Guangdong/20SFO0 14/2020

14 - BetaCoV/Wuhan/IV DC-HB-04/2020

28 - BetaCoV/Guangdong/20SFO0 13/2020

Figure 8. +3 reading frame network.

26/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Table 17. Cluster memberships of the nucleotide sequences (network for +3 reading
frames).
Sequence ID

In-degree

Out-degree

Degree

Cluster

2 - BetaCov/Wuhan/WHO01/2019
6 - BetaCoV/Wuhan/WIV02/2019
7 - BetaCoV/Wuhan/WIV05/2019
8 - BetaCoV/Wuhan/WIV06/2019
9 - BetaCoV/Wuhan/WIV07/2019
16 - BetaCov/Wuhan/WH03/2020
19 - BetaCov/Wuhan/WH04/2020
21 - BetaCoV/Shenzhen/HKU-SZ-002/2020
32 - BetaCoV/Zhejiang/WZ-0 1/2020
33 - BetaCoV/Shenzhen/SZTH-003/2020
34 - BetaCoV/Shenzhen/SZTH-004/2020
36 - BetaCoV/Zhejiang/WZ-02/2020
42 - BetaCoV/Hangzhou/HZCDC000 1/2020
45 - BetaCoV/Zhejiang/Hangzhou- 1/2020
55 - BetaCoV/Taiwan/2/2020
59 - BetaCoV/France/IDF0373/2020
62 - BetaCoV/Australia/NS WO 1/2020
64 - BetaCoV/Japan/AI/I-004/2020
65 - BetaCoV/Korea/KCDC03/2020
69 - BetaCoV/Germany/BavPat 1/2020
70 - BetaCoV/Australia/QLD0O1/2020
79 - BetaCoV/Australia/QLD02/2020
80 - BetaCoV/Taiwan/NTU01/2020
81 - BetaCoV/Singapore/3/2020
1 - BetaCoV/Wuhan/IPBCAMS-WH-01/2019
3 - BetaCoV/Wuhan/IV DC-HB-01/2019
4 - BetaCoV/Wuhan/IV DC-HB-05/2019
5 - BetaCoV/Wuhan/WIV04/2019
11 - BetaCoV/Wuhan/IPBCAMS-WH-04/2019
12 - BetaCoV/Wuhan/IPBCAMS-WH-03/2019
13 - BetaCoV/Wuhan/IPBCAMS-WH-02/2019
14 - BetaCoV/Wuhan/IV DC-HB-04/2020
15 - BetaCoV/Wuhan/IPBCAMS-WH-05/2020
17 - BetaCoV/China/WHU01/2020
18 - BetaCoV/China/WHU02/2020
40 - BetaCoV/Beijing/IV DC-BJ-005/2020
44 - BetaCoV/Jiangsu/IVDC-JS-00 1/2020
68 - BetaCoV/Singapore/2/2020
77 - BetaCo V/France/IDF05 15/2020
22 - BetaCoV/Shenzhen/HKU-SZ-005/2020
23 - BetaCoV/Jiangxi/IV DC-JX-002/2020
25 - BetaCoV/Shenzhen/SZTH-00 1/2020
26 - BetaCoV/Shenzhen/SZTH-002/2020
31 - BetaCoV/Sichuan/ITVDC-SC-00 1/2020
37 - BetaCoV/Yunnan/IVDC- Y N-003/2020
39 - BetaCoV/Chongqing/IVDC-CQ-00 1/2020
41 - BetaCoV/USA/WA 1/2020
43 - BetaCoV/Shandong/IVDC-SD-00 1/2020
10 - BetaCoV/Wuhan/HBCDC-HB-01/2019
20 - BetaCoV/Nonthaburi/6 1/2020
24 - BetaCoV/Nonthaburi/74/2020
27 - BetaCoV/Guangdong/20SFO0 12/2020
28 - BetaCoV/Guangdong/20SFO0 13/2020
29 - BetaCoV/Guangdong/20SFO0 14/2020
30 - BetaCoV/Guangdong/20SF025/2020
35 - BetaCoV/Guangdong/20SF028/2020
38 - BetaCoV/Guangdong/20SF040/2020
58 - BetaCo V/France/IDF0372/2020
78 - BetaCov/France/IDF0626/2020
46 - BetaCoV/USA/IL 1/2020
47 - BetaCoV/Chonggqing/Y C0 1/2020
48 - BetaCoV/USA/CA2/2020
49 - BetaCoV/USA/AZ1/2020
56 - BetaCoV/USA/CA1/2020
60 - BetaCoV/Singapore/ 1/2020
61 - BetaCoV/Chonggqing/ZX0 1/2020
50 - BetaCoV/Guangdong/20SF174/2020
51 - BetaCoV/Guangzhou/20SF206/2020
52 - BetaCo V/Foshan/20SF207/2020
53 - BetaCo V/Foshan/20SF2 10/2020
54 - BetaCoV/Foshan/20SF21 1/2020
57 - BetaCoV/Guangdong/20SF201/2020
63 - BetaCoV/Australia/VICO1/2020
66 - BetaCoV/USA/WA1-A12/2020
67 - BetaCoV/USA/W A 1-F6/2020
71 - BetaCoV/England/01/2020
72 - BetaCoV/England/02/2020
73 - BetaCoV/Finland/1/2020
74 - BetaCoV/USA/CA3/2020
75 - BetaCoV/USA/CA4/2020
76 - BetaCoV/USA/CA5/2020
82 - BetaCoV/Belgium/GHB-0302 1/2020

1
2
3
4
5
7
9
10
13
16
13
17
16
18
20
14
22
22
22
8
10
24
27
25
0
2
1
2
6
3
3
2
3
8
1
12
6
13
7
8
2
4
3
4
7
4
5
5
6
5
3
2
1
2
2
6
3
12
10
4
20
3
6
5
7
7
18
5
2
2
1
5
14
8
1
5
3
4
3
1
3
8

31
25
25
24
24
23
23
19
13
18
17
16
14
15
13
10
5
8
5
7
6
3
2
1
3
2
2
7
2
3
3
3
8
1
11
9
11
5
5
4
6
5
7
8
3
3
6
7
5
3
4
1
2
2
7
3
11
12
4
3
9
5
5
7
4
12
2
2
3
2
3
13
8
1
6
2
3
2
1
2
6
0

32
27
28
28
29
30
32
29
26
34
30
33
30
33
33
24
27
30
27
15
16
27
29
26
3
4
3
9
8
6
6
5
11
9
12
21
17
18
12
12
8
9
10
12
10
7
11
12
11
8
7
3
3
4
9
9
14
24
14
7
29
8
11
12
11
19
20
7
5
4
4
18
22
9
7
7
6
6
4
3
9
8

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
4
5
5
5
5
5
5
5
6
6
6
6
6
6
7
7
7
7
7
7
7
7
7
7

Table 18. Intra-cluster similarities (network for +3 reading frames).
Cluster

Avg. similarity

SD

Min. similarity

Max. similarity

Cluster size

0
1
2
3
4
5
6
7

0.277353
0.999730
0.998768
0.999388
0.999915
0.896098
0.999926
0.997900

0.088247
0.000222
0.001345
0.000391
0.000048
0.111390
0.000036
0.002419

0.250620
0.999231
0.996387
0.998461
0.999832
0.781909
0.999866
0.991158

0.999866
1.000000
1.000000
0.999933
1.000000
0.999899
1.000000
1.000000

24
9
6
9
11
7
6
10

27/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Acknowledgements
We want to thank the laboratories and researchers who contributed the genomic research
data used in this study and obtained via the GISAID EpiFlu Database™ 3 on Monday,
February 10th 2020. The following tables contain information about the origination of
the research data used in this study and give credit to the collecting and submitting
researchers and laboratories.

3 https://www.gisaid.org/

28/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Table 19. Nucleotide sequences used in this study that were obtained from the GISAID EpiFlu Database™.
Collection date

Sequence id

Originating lab

Submitting lab

Authors

24/12/19

BetaCoV/Wuhan/IPBCAMS-WH01/2019

Institute
Biology

Lili Ren, Jianwei Wang, Qi Jin, Zichun
Xiang, Zhigiang Wu, Chao Wu, Yiwei
Liu

26/12/19

BetaCov/Wuhan/WHO01/2019

30/12/19

BetaCoV/Wuhan/IV DC-HB-01/2019

General
Hospital
of
Central Theater Command of People
National Institute for
Viral Disease Control
and Prevention

Institute
Biology,
Academy
Sciences
BGI

30/12/19

BetaCoV/Wuhan/IV DC-HB-05/2019

National Institute for
Viral Disease Control
and Prevention

National Institute for
Viral Disease Control
and Prevention, China
CDC

30/12/19

BetaCoV/Wuhan/WIV04/2019

Wuhan Jinyintan Hospital

30/12/19

BetaCoV/Wuhan/WIV02/2019

Wuhan Jinyintan Hospital

30/12/19

BetaCoV/Wuhan/WIV05/2019

Wuhan Jinyintan Hospital

30/12/19

BetaCoV/Wuhan/WIV06/2019

Wuhan Jinyintan Hospital

30/12/19

BetaCoV/Wuhan/WIV07/2019

Wuhan Jinyintan Hospital

30/12/19

BetaCoV/Wuhan/HBCDC-HB01/2019

Wuhan Jinyintan Hospital

Wuhan
Institute
of
Virology,
Chinese
Academy of Sciences
Wuhan
Institute
of
Virology,
Chinese
Academy of Sciences
Wuhan
Institute
of
Virology,
Chinese
Academy of Sciences
Wuhan
Institute
of
Virology,
Chinese
Academy of Sciences
Wuhan
Institute
of
Virology,
Chinese
Academy of Sciences
Hubei Provincial Center
for Disease Control and
Prevention

30/12/19

BetaCoV/Wuhan/IPBCAMS-WH04/2019

Institute
Biology

of

Pathogen

30/12/19

BetaCoV/Wuhan/IPBCAMS-WH03/2019

Institute
Biology

of

Pathogen

30/12/19

BetaCoV/Wuhan/IPBCAMS-WH02/2019

Institute
Biology

of

Pathogen

1/01/20

BetaCoV/Wuhan/IV DC-HB-04/2020

National Institute for
Viral Disease Control
and Prevention

1/01/20

BetaCoV/Wuhan/IPBCAMS-WH05/2020

Institute
Biology

of

of

Pathogen

Pathogen

of

Pathogen
Chinese
of
Medical

Weijun Chen, Yuhai Bi, Weifeng Shi
and Zhenhong Hu

National Institute for
Viral Disease Control
and Prevention, China
CDC

Institute of Pathogen
Biology,
Chinese
Academy
of
Medical
Sciences
Institute of Pathogen
Biology,
Chinese
Academy
of
Medical
Sciences
Institute of Pathogen
Biology,
Chinese
Academy
of
Medical
Sciences
National Institute for
Viral Disease Control
and Prevention, China
CDC

Institute
Biology,
Academy
Sciences
BGI

of
of

Pathogen
Chinese
Medical

1/01/20

BetaCov/Wuhan/WH03/2020

2/01/20

BetaCoV/China/WHU01/2020

General
Hospital
of
Central Theater Command of People
unknown

2/01/20

BetaCoV/China/WHU02/2020

unknown

State Key Laboratory
of Virology, Wuhan University

5/01/20

BetaCov/Wuhan/WH04/2020

BGI

8/01/20

BetaCoV/Nonthaburi/6 1/2020

General
Hospital
of
Central Theater Command of People
Bamrasnaradura Hospital

10/01/20

BetaCoV/Shenzhen/HKU-SZ002/2020

The University of Hong
Kong - Shenzhen Hospital

1. Department of Medical Sciences, Ministry
of Public Health, Thailand
Li Ka Shing Faculty of
Medicine, The University of Hong Kong

11/01/20

BetaCoV/Shenzhen/HKU-SZ005/2020

The University of Hong
Kong - Shenzhen Hospital

Li Ka Shing Faculty of
Medicine, The University of Hong Kong

11/01/20

BetaCoV/Jiangxi/IV
002/2020

National Institute for
Viral Disease Control
and Prevention

National Institute for
Viral Disease Control

DC-JX-

State Key Laboratory
of Virology, Wuhan University

Wenjie TanXiang ZhaoWenling Wang
Xuejun MaYongzhong JiangRoujian
Lu, Ji Wang, Weimin ZhouPeihua
NiuPeipei
LiuFaxian
ZhanWeifeng
ShiBaoying HuangJun LiuLi ZhaoYao
MengXiaozhou HeFei YeNa ZhuYang
LiJing
ChenWenbo
XuGeorge
F.
GaoGuizhen Wu
Wenjie TanXuejun MaXiang ZhaoWenling Wang Yongzhong JiangRoujian
LuJi WangPeihua Niu, Weimin Zhou,
Faxian
ZhanWeifeng
ShiBaoying
HuangJun LiuLi ZhaoYao MengFei
YeNa Zhu, Xiaozhou HePeipei Liu,
Yang LiJing ChenWenbo XuGeorge F.
GaoGuizhen Wu
Peng Zhou, Xing-Lou Yang, Ding-Yu
Zhang, Lei Zhang, Yan Zhu, Hao-Rui
Si, Zhengli Shi
Peng Zhou, Xing-Lou Yang, Ding-Yu
Zhang, Lei Zhang, Yan Zhu, Hao-Rui
Si, Zhengli Shi
Peng Zhou, Xing-Lou Yang, Ding-Yu
Zhang, Lei Zhang, Yan Zhu, Hao-Rui
Si, Zhengli Shi
Peng Zhou, Xing-Lou Yang, Ding-Yu
Zhang, Lei Zhang, Yan Zhu, Hao-Rui
Si, Zhengli Shi
Peng Zhou, Xing-Lou Yang, Ding-Yu
Zhang, Lei Zhang, Yan Zhu, Hao-Rui
Si, Zhengli Shi
Bin Fang, Xiang Li, Xiao Yu, Linlin
Liu, Bo Yang, Faxian Zhan, Guojun
Ye, Xixiang Huo, Jungiang Xu, Bo Yu,
Kun Cai, Jing Li, Yongzhong Jiang.
Lili Ren, Jianwei Wang, Qi Jin, Zichun
Xiang, Zhigiang Wu, Chao Wu, Yiwei
Liu
Lili Ren, Jianwei Wang, Qi Jin, Zichun
Xiang, Zhigiang Wu, Chao Wu, Yiwei
Liu
Lili Ren, Jianwei Wang, Qi Jin, Zichun
Xiang, Zhigiang Wu, Chao Wu, Yiwei
Liu
Wenjie
TanXiang
ZhaoWenling
WangXuejyun
MaYongzhong
JiangRoujian LuJi WangWeimin ZhouPeihua NiuPeipei LiuFaxian ZhanWeifeng
ShiBaoying HuangJun LiuLi ZhaoYao
MengXiaozhou HeFei YeNa ZhuYang
LiJing
ChenWenbo
XuGeorge
F.
GaoGuizhen Wu
Lili Ren, Jianwei Wang, Qi Jin, Zichun
Xiang, Zhigiang Wu, Chao Wu, Yiwei
Liu
Weijun Chen, Yuhai Bi, Weifeng Shi
and Zhenhong Hu
Chen,L., Liu,W., Zhang,Q., Xu,K.,
Ye,G., Wu,W., Sun,Z., Liu,F., Wu,K.,
Mei, Y., Zhang,W., Chen, Y., Li,Y.,
Shi,M., Lan,K. and Liu,Y.
Chen,L., Liu,W., Zhang,Q., Xu,K.,
Ye,G., Wu,W., Sun,Z., Liu,F., Wu,K.,
Mei, Y., Zhang,W., Chen, Y., Li,Y.,
Shi,M., Lan,K. and Liu,Y.
Weijun Chen, Yuhai Bi, Weifeng Shi
and Zhenhong Hu
NA

Chan,J.F.-W.,
Yuan,S.,
Kok,K.H.,
To,K.K.-W., Chu,H., Yang,J., Xing,F.,
Liu,J.,
Yip,C.C.-Y.,
Poon,R.W–S.,
Tsai,H.W.,
Lo,S.K.-F.,
Chan,K.H.,
Poon,V.K.-M., Chan,W.M.., Ip,J.D.,
Cai,J.P.,
Cheng,V.C.-C.,
Chen,H.,
Hui,C.K.-M. and Yuen,K.Y.
Chan,J.F.-W.,
Yuan,S.,
Kok,K.H.,
To,K.K.-W., Chu,H., Yang,J., Xing,F.,
Liu,J.,
Yip,C.C.-Y.,
Poon,R.W–S.,
Tsai,H.W.,
Lo,S.K.-F.,
Chan,K.H.,
Poon,V.K.-M., Chan,W.M.., Ip,J.D.,
Cai,J.P.,
Cheng,V.C.-C.,
Chen,H.,
Hui,C.K.-M. and Yuen,K.Y.
Wenjie Tan, Yong Shi, Wenling Wang,
Peihua Niu, Roujian Lu, Jianxiong Li,
Xiang Zhao, Baoying Huang, Li Zhao,
Fei Ye, Wenbo Xu, George F. Gao,
Guizhen Wu

29/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Table 20. Nucleotide sequences used in this study that were obtained from the GISAID EpiFlu Database™(contd.).
Collection date

Sequence id

Originating lab

Submitting lab

Authors

13/01/20

BetaCoV/Nonthaburi/74/2020

Bamrasnaradura Hospital

NA

13/01/20

BetaCoV/Shenzhen/SZTH-00 1/2020

Shenzhen Third People

13/01/20

BetaCoV/Shenzhen/SZTH-002/2020

Shenzhen Key Laboratory of Pathogen and
Immunity

14/01/20

BetaCoV/Guangdong/20SFO0
12/2020

Guangdong Provincial
Center
for
Diseases
Control and Prevention

1. Department of Medical Sciences, Ministry
of Public Health, Thailand
Shenzhen
Key
Laboratory
of
Pathogen
and
Immunity,
National Clinical Research
Center for Infectious
Shenzhen
Key
Laboratory
of
Pathogen
and
Immunity,
National Clinical Research
Center for Infectious
Disease,
Department of Microbiology,
Guangdong
Provincial Center for
Diseases Control and
Prevention

15/01/20

BetaCoV/Guangdong/20SFO0
13/2020

Guangdong Provincial
Center
for
Diseases
Control and Prevention

Department of Microbiology,
Guangdong
Provincial Center for
Diseases Control and
Prevention

15/01/20

BetaCoV/Guangdong/20SFO0
14/2020

Guangdong Provincial
Center
for
Diseases
Control and Prevention

Department of Microbiology,
Guangdong
Provincial Center for
Diseases Control and
Prevention

15/01/20

BetaCoV/Guangdong/20SF025/2020

Guangdong Provincial
Center
for
Diseases
Control and Prevention

Department of Microbiology,
Guangdong
Provincial Center for
Diseases Control and
Prevention

15/01/20

BetaCoV/Sichuan/ITVDC-SC-00
1/2020

National Institute for
Viral Disease Control
and Prevention

National Institute for
Viral Disease Control

16/01/20

BetaCoV/Zhejiang/WZ-0 1/2020

Zhejiang
Provincial
Center
for
Disease
Control and Prevention

Department of Microbiology, Zhejiang Provincial Center for Disease
Control and Prevention

16/01/20

BetaCoV/Shenzhen/SZTH-003/2020

Shenzhen Key Laboratory of Pathogen and
Immunity

16/01/20

BetaCoV/Shenzhen/SZTH-004/2020

Shenzhen Key Laboratory of Pathogen and
Immunity

17/01/20

BetaCoV/Guangdong/20SF028/2020

Guangdong Provincial
Center
for
Diseases
Control and Prevention

Shenzhen
Key
Laboratory
of
Pathogen
and
Immunity,
National Clinical Research
Center for Infectious
Disease,
Shenzhen
Key
Laboratory
of
Pathogen
and
Immunity,
National Clinical Research
Center for Infectious
Disease,
Department of Microbiology,
Guangdong
Provincial Center for
Diseases Control and
Prevention

Yang Yang, Chenguang Shen, Li Xing,
Zhixiang Xu, Haixia Zheng, Yingxia
Liu

Yang Yang, Chenguang Shen, Li Xing,
Zhixiang Xu, Haixia Zheng, Yingxia
Liu

Min Kang, Jie Wu, Jing Lu, Tao
Liu, Baisheng Li, Shujiang Mei, Feng
Ruan, Lifeng Lin, Changwen Ke, Haojie Zhong, Yingtao Zhang, Lirong
Zou, Xuguang Chen, Qi Zhu, Jianpeng Xiao, Jianxiang Geng, Zhe Liu,
Jianxiong Hu, Weilin Zeng, Xing
Li, Yuhuang Liao, Xiujuan Tang,
Songjian Xiao, Ying Wang, Yingchao
Song, Xue Zhuang, Liyun Liang,
Guanhao He, Huihong Deng, Tie Song,
Jianfeng He, Wenjun Ma
Min Kang, Jie Wu, Jing Lu, Tao
Liu, Baisheng Li, Shujiang Mei, Feng
Ruan, Lifeng Lin, Changwen Ke, Haojie Zhong, Yingtao Zhang, Lirong
Zou, Xuguang Chen, Qi Zhu, Jianpeng Xiao, Jianxiang Geng, Zhe Liu,
Jianxiong Hu, Weilin Zeng, Xing
Li, Yuhuang Liao, Xiujuan Tang,
Songjian Xiao, Ying Wang, Yingchao
Song, Xue Zhuang, Liyun Liang,
Guanhao He, Huihong Deng, Tie Song,
Jianfeng He, Wenjun Ma
Min Kang, Jie Wu, Jing Lu, Tao
Liu, Baisheng Li, Shujiang Mei, Feng
Ruan, Lifeng Lin, Changwen Ke, Haojie Zhong, Yingtao Zhang, Lirong
Zou, Xuguang Chen, Qi Zhu, Jianpeng Xiao, Jianxiang Geng, Zhe Liu,
Jianxiong Hu, Weilin Zeng, Xing
Li, Yuhuang Liao, Xiujuan Tang,
Songjian Xiao, Ying Wang, Yingchao
Song, Xue Zhuang, Liyun Liang,
Guanhao He, Huihong Deng, Tie Song,
Jianfeng He, Wenjun Ma
Min Kang, Jie Wu, Jing Lu, Tao
Liu, Baisheng Li, Shujiang Mei, Feng
Ruan, Lifeng Lin, Changwen Ke, Haojie Zhong, Yingtao Zhang, Lirong
Zou, Xuguang Chen, Qi Zhu, Jianpeng Xiao, Jianxiang Geng, Zhe Liu,
Jianxiong Hu, Weilin Zeng, Xing
Li, Yuhuang Liao, Xiujuan Tang,
Songjian Xiao, Ying Wang, Yingchao
Song, Xue Zhuang, Liyun Liang,
Guanhao He, Huihong Deng, Tie Song,
Jianfeng He, Wenjun Ma
Wenjie Tan, Jianan Xu, Wenling
Wang, Peihua Niu, Roujian Lu, Huiping Yang, Xiang Zhao, Baoying Huang,
Li Zhao, Fei Ye, Wenbo Xu, George F.
Gao, Guizhen Wu
Yin Chen, Yanjun Zhang, Haiyan Mao,
Junhang Pan, Xiuyu Lou, Yiyu Lu,
Juying Yan, Hanping Zhu, Jian Gao,
Yan Feng, Yi Sun, Hao Yan, Zhen Li,
Yisheng Sun, Liming Gong, Qiong Ge,
Wen Shi, Xinying Wang, Wenwu Yao,
Zhangnv Yang, Fang Xu, Chen Chen,
Enfu Chen, Zhen Wang, Zhiping Chen,
Jianmin Jiang, Chonggao Hu
Yang Yang, Chenguang Shen, Li Xing,
Zhixiang Xu, Haixia Zheng, Yingxia
Liu

Yang Yang, Chenguang Shen, Li Xing,
Zhixiang Xu, Haixia Zheng, Yingxia
Liu

Min Kang, Jie Wu, Jing Lu, Tao
Liu, Baisheng Li, Shujiang Mei, Feng
Ruan, Lifeng Lin, Changwen Ke, Haojie Zhong, Yingtao Zhang, Lirong
Zou, Xuguang Chen, Qi Zhu, Jianpeng Xiao, Jianxiang Geng, Zhe Liu,
Jianxiong Hu, Weilin Zeng, Xing
Li, Yuhuang Liao, Xiujuan Tang,
Songjian Xiao, Ying Wang, Yingchao
Song, Xue Zhuang, Liyun Liang,
Guanhao He, Huihong Deng, Tie Song,
Jianfeng He, Wenjun Ma

30/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Table 21. Nucleotide sequences used in this study that were obtained from the GISAID EpiFlu Database™(contd.).
Collection date

Sequence id

Originating lab

Submitting lab

Authors

17/01/20

BetaCoV/Zhejiang/WZ-02/2020

Zhejiang
Provincial
Center
for
Disease
Control and Prevention

Department of Microbiology, Zhejiang Provincial Center for Disease
Control and Prevention

17/01/20

BetaCoV/Yunnan/IVDC003/2020

National Institute for
Viral Disease Control
and Prevention

National Institute for
Viral Disease Control

18/01/20

BetaCoV/Guangdong/20SF040/2020

Guangdong Provincial
Center
for
Diseases
Control and Prevention

Department of Microbiology,
Guangdong
Provincial Center for
Diseases Control and
Prevention

18/01/20

BetaCoV/Chongqing/IVDC-CQ-00
1/2020

National Institute for
Viral Disease Control
and Prevention

National Institute for
Viral Disease Control

18/01/20

BetaCoV/Beijing/IV DC-BJ-005/2020

National Institute for
Viral Disease Control
and Prevention

National Institute for
Viral Disease Control

19/01/20

BetaCoV/USA/WA 1/2020

Providence
Regional
Medical Center

19/01/20

BetaCoV/Hangzhou/HZCDC000
1/2020

Hangzhou Center for
Disease
Control
and
Prevention

Division of Viral
eases, Centers for
ease Control and
vention
Hangzhou Center
Disease
Control
Prevention

Yanjun Zhang, Yin Chen, Haiyan Mao,
Junhang Pan, Xiuyu Lou, Yiyu Lu,
Juying Yan, Hanping Zhu, Jian Gao,
Yan Feng, Yi Sun, Hao Yan, Zhen Li,
Yisheng Sun, Liming Gong, Qiong Ge,
Wen Shi, Xinying Wang, Wenwu Yao,
Zhangnv Yang, Fang Xu, Chen Chen,
Enfu Chen, Zhen Wang, Zhiping Chen,
Jianmin Jiang, Chonggao Hu
Wenjie
TanXiaoging
FuXiang
ZhaoWenling
Wang
Peihua
NiuRoujian
Lu,Yanhong
SunBaoying
HuangLi ZhaoFei YeWenbo XuGeorge
F. GaoGuizhen Wu
Min Kang, Jie Wu, Jing Lu, Tao
Liu, Baisheng Li, Shujiang Mei, Feng
Ruan, Lifeng Lin, Changwen Ke, Haojie Zhong, Yingtao Zhang, Lirong
Zou, Xuguang Chen, Qi Zhu, Jianpeng Xiao, Jianxiang Geng, Zhe Liu,
Jianxiong Hu, Weilin Zeng, Xing
Li, Yuhuang Liao, Xiujuan Tang,
Songjian Xiao, Ying Wang, Yingchao
Song, Xue Zhuang, Liyun Liang,
Guanhao He, Huihong Deng, Tie Song,
Jianfeng He, Wenjun Ma
Wenjie Tan, Henggin Wang, Xiang
Zhao, Wenling Wang, Peihua Niu,
Roujian Lu, Sheng Ye, Baoying Huang,
Li Zhao, Fei Ye, Wenbo Xu, George F.
Gao, Guizhen Wu
Wenjie
Tan,Quanyi
Wang,Wenling
Wang, Peihua Niu,Roujian Lu,Yang
Pan,Xiang Zhao,Baoying Huang,Li
Zhao,Fei Ye,Wenbo Xu,George F.
Gao,Guizhen Wu
Queen,K., Tao, Y., Li,Y., Paden,C.R.,
Lu,X., Zhang,J., Gerber,S.I., Lindstrom,S., Tong,S.

19/01/20

BetaCoV/Shandong/IVDC-SD-00
1/2020

National Institute for
Viral Disease Control
and Prevention

National Institute for
Viral Disease Control

19/01/20

BetaCoV/Jiangsu/IVDC-JS-00
1/2020

National Institute for
Viral Disease Control
and Prevention

National Institute for
Viral Disease Control

20/01/20

BetaCoV/Zhejiang/Hangzhou- 1/2020

21/01/20

BetaCoV/USA/IL 1/2020

Hangzhou Center for
Disease and Control Microbiology Lab
IL Department of Public Health Chicago Laboratory

21/01/20

BetaCoV/Chonggqing/Y C0 1/2020

Yongchuan
District
Center
for
Disease
Control and Prevention

Hangzhou Center for
Disease and Control Microbiology Lab
Pathogen
Discovery,
Respiratory
Viruses
Branch,
Division
of
Viral Diseases, Centers
for Dieases Control and
Chongqing
Municipal
Center
for
Disease
Control and Prevention

22/01/20

BetaCoV/USA/CA2/2020

California Department
of Public Health

22/01/20

BetaCoV/USA/AZ1/2020

Arizona Department of
Health Services

22/01/20

BetaCoV/Guangdong/20SF174/2020

Guangdong Provincial
Center
for
Diseases
Contorl and Prevention

Pathogen
Discovery,
Respiratory
Viruses
Branch,
Division
of
Viral Diseases, Centers
for Dieases Control and
Pathogen
Discovery,
Respiratory
Viruses
Branch,
Division
of
Viral Diseases, Centers
for Disease Control and
Guangdong Provincial
Center
for
Disease
Control and Prevention

22/01/20

BetaCoV/Guangzhou/20SF206/2020

Guangdong Provincial
Center
for
Diseases
Contorl and Prevention

Guangdong Provincial
Center
for
Diseases
Control and Prevention

Y

N-

DisDisPrefor
and

Jun Li, Haogiu Wang, Hua Yu,
Lingfeng Mao, Xinfen Yu, Zhou Sun,
Qingxin Kong, Xin Qian, Shuchang
Chen, Xuchu Wang
Wenjie Tan, Zhaoguo Wang, Xiang
Zhao, Wenling Wang, Peihua Niu,
Roujian Lu, Ti Liu, Baoying Huang,
Li Zhao, Fei Ye, Wenbo Xu, George F.
Gao, Guizhen Wu
Wenjie Tan, Shenjiao Wang, Wenling Wang, Peihua Niu, Roujian Lu,
Kangchen Zhao, Xiang Zhao, Baoying
Huang, Li Zhao, Fei Ye, Wenbo Xu,
George F. Gao, Guizhen Wu
Yu Hua, Wang Haogiu, Li Jun, Yu Xinfeng
NA

Ye Sheng, Tang Yun, Ling Hua, Yu
zhen,Chen Shuang,Tan ZhangPing, Su
Kun, Li Qing, Tang Wenge, Rong
Rong
NA

NA

Min Kang, Jie Wu, Jing Lu, Tao
Liu, Baisheng Li, Shujiang Mei, Feng
Ruan, Lifeng Lin, Changwen Ke, Haojie Zhong, Yingtao Zhang, Lirong
Zou, Xuguang Chen, Qi Zhu, Jianpeng Xiao, Jianxiang Geng, Zhe Liu,
Jianxiong Hu, Weilin Zeng, Xing
Li, Yuhuang Liao, Xiujuan Tang,
Songjian Xiao, Ying Wang, Yingchao
Song, Xue Zhuang, Liyun Liang,
Guanhao He, Huihong Deng, Tie Song,
Jianfeng He, Wenjun Ma
Min Kang, Jie Wu, Jing Lu, Tao
Liu, Baisheng Li, Shujiang Mei, Feng
Ruan, Lifeng Lin, Changwen Ke, Haojie Zhong, Yingtao Zhang, Lirong
Zou, Xuguang Chen, Qi Zhu, Jianpeng Xiao, Jianxiang Geng, Zhe Liu,
Jianxiong Hu, Weilin Zeng, Xing
Li, Yuhuang Liao, Xiujuan Tang,
Songjian Xiao, Ying Wang, Yingchao
Song, Xue Zhuang, Liyun Liang,
Guanhao He, Huihong Deng, Tie Song,
Jianfeng He, Wenjun Ma

31/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Table 22. Nucleotide sequences used in this study that were obtained from the GISAID EpiFlu Database™(contd.).
Collection date

Sequence id

Originating lab

Submitting lab

Authors

22/01/20

BetaCo V/Foshan/20SF207/2020

Guangdong Provincial
Center
for
Diseases
Control and Prevention

Guangdong Provincial
Center
for
Diseases
Control and Prevention

22/01/20

BetaCo V/Foshan/20SF2 10/2020

Guangdong Provincial
Center
for
Diseases
Control and Prevention

Guangdong Provincial
Center
for
Diseases
Control and Prevention

22/01/20

BetaCoV/Foshan/20SF21 1/2020

Guangdong Provincial
Center
for
Diseases
Control and Prevention

Guangdong Provincial
Center
for
Diseases
Control and Prevention

23/01/20

BetaCoV/Taiwan/2/2020

23/01/20

BetaCoV/USA/CA1/2020

Centers for Disease Control
California Department
of Public Health

23/01/20

BetaCoV/Guangdong/20SF201/2020

Guangdong Provincial
Center
for
Diseases
Control and Prevention

Centers for Disease Control, R.O.C.
Pathogen
Discovery,
Respiratory
Viruses
Branch,
Division
of
Viral Diseases, Centers
for Dieases Control and
Guangdong Provincial
Center
for
Diseases
Control and Prevention

Min Kang, Jie Wu, Jing Lu, Tao
Liu, Baisheng Li, Shujiang Mei, Feng
Ruan, Lifeng Lin, Changwen Ke, Haojie Zhong, Yingtao Zhang, Lirong
Zou, Xuguang Chen, Qi Zhu, Jianpeng Xiao, Jianxiang Geng, Zhe Liu,
Jianxiong Hu, Weilin Zeng, Xing
Li, Yuhuang Liao, Xiujuan Tang,
Songjian Xiao, Ying Wang, Yingchao
Song, Xue Zhuang, Liyun Liang,
Guanhao He, Huihong Deng, Tie Song,
Jianfeng He, Wenjun Ma
Min Kang, Jie Wu, Jing Lu, Tao
Liu, Baisheng Li, Shujiang Mei, Feng
Ruan, Lifeng Lin, Changwen Ke, Haojie Zhong, Yingtao Zhang, Lirong
Zou, Xuguang Chen, Qi Zhu, Jianpeng Xiao, Jianxiang Geng, Zhe Liu,
Jianxiong Hu, Weilin Zeng, Xing
Li, Yuhuang Liao, Xiujuan Tang,
Songjian Xiao, Ying Wang, Yingchao
Song, Xue Zhuang, Liyun Liang,
Guanhao He, Huihong Deng, Tie Song,
Jianfeng He, Wenjun Ma
Min Kang, Jie Wu, Jing Lu, Tao
Liu, Baisheng Li, Shujiang Mei, Feng
Ruan, Lifeng Lin, Changwen Ke, Haojie Zhong, Yingtao Zhang, Lirong
Zou, Xuguang Chen, Qi Zhu, Jianpeng Xiao, Jianxiang Geng, Zhe Liu,
Jianxiong Hu, Weilin Zeng, Xing
Li, Yuhuang Liao, Xiujuan Tang,
Songjian Xiao, Ying Wang, Yingchao
Song, Xue Zhuang, Liyun Liang,
Guanhao He, Huihong Deng, Tie Song,
Jianfeng He, Wenjun Ma
Ji-Rong Yang, Yu-Chi Lin, Jung-Jung
Mu, Ming-Tsan Liu, Shu- Ying Li
NA

23/01/20

BetaCo V/France/IDF0372/2020

Department
tious
and
Diseases

of InfecTropical

National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris

23/01/20

BetaCoV/France/IDF0373/2020

Department
tious
and
Diseases

of InfecTropical

National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris

23/01/20

BetaCoV/Singapore/ 1/2020

23/01/20

BetaCoV/Chonggqing/ZX0 1/2020

Singapore General Hospital
Zhongxian Center for
Disease
Control
and
Prevention

National Public Health
Laboratory
Chongqing
Municipal
Center
for
Disease
Control and Prevention

24/01/20

BetaCoV/Australia/NS WO 1/2020

25/01/20

BetaCoV/Australia/VICO1/2020

Centre for Infectious
Diseases
and
Microbiology
Laboratory
Services
Monash Medical Centre

25/01/20

BetaCoV/Japan/AI/I-004/2020

Department of Virology
III

25/01/20

BetaCoV/Korea/KCDC03/2020

Korea Centers for Disease Control

NSW Health Pathology
- Institute of Clinical
Pathology and Medical
Research
Collaboration between
the University of Melbourne at The Peter Doherty Institute for Infection and Immunity, and
Pathogen
Genomics
Center,
National Institute
of
Infectious
Diseases
Korea Centers for Disease Control

25/01/20

BetaCoV/USA/WA1-A12/2020

WA State Department
of Health

25/01/20

BetaCoV/USA/W A 1-F6/2020

WA State Department
of Health

25/01/20

BetaCoV/Singapore/2/2020

Singapore General Hospital

Pathogen
Discovery,
Respiratory
Viruses
Branch,
Division
of
Viral Diseases, Centers
for Dieases Control and
Pathogen
Discovery,
Respiratory
Viruses
Branch,
Division
of
Viral Diseases, Centers
for Dieases Control and
Programme in Emerging Infectious Diseases,
Duke-NUS
Medical
School

Min Kang, Jie Wu, Jing Lu, Tao
Liu, Baisheng Li, Shujiang Mei, Feng
Ruan, Lifeng Lin, Changwen Ke, Haojie Zhong, Yingtao Zhang, Lirong
Zou, Xuguang Chen, Qi Zhu, Jianpeng Xiao, Jianxiang Geng, Zhe Liu,
Jianxiong Hu, Weilin Zeng, Xing
Li, Yuhuang Liao, Xiujuan Tang,
Songjian Xiao, Ying Wang, Yingchao
Song, Xue Zhuang, Liyun Liang,
Guanhao He, Huihong Deng, Tie Song,
Jianfeng He, Wenjun Ma
Mélanie Albert, Marion Barbet, Sylvie
Behillil, Méline Bizard, Angela Brisebarre, Flora Donati, Vincent Enouf,
Maud Vanpeene, Sylvie van der Werf,
Yazdan Yazdanpanah, Xavier Lescure.
Mélanie Albert, Marion Barbet, Sylvie
Behillil, Méline Bizard, Angela Brisebarre, Flora Donati, Vincent Enouf,
Maud Vanpeene, Sylvie van der Werf,
Yazdan Yazdanpanah, Xavier Lescure.
NA
Ye Sheng, Tang Yun, Ling Hua, Zhang
Hong,
Yu zhen,Chen Shuang,Tan
ZhangPing, Su Kun, Li Qin, Tang
Wenge, Rong Rong
NA

Caly,L.,
Seemann,T.,
Druce,J. and Taiaroa,G

Schultz,M.,

Tsuyoshi Sekizuka,
Shutoku Matsuyama,
Naganori
Nao,
Kazuya
Shirato, Shinji Watanabe, Makoto
Takeda, Makoto Kuroda
Jeong-Min Kim, Yoon-Seok Chung,
Namjoo Lee, Mi-Seon Kim, SangHee
Woo, Hye-Joon Jo, Sehee Park, Heui
Man Kim, Myung Guk Han
NA

NA

Danielle E Anderson, Martin Linster, Yan Zhuang, Jayanthi Jayakumar, Kian Sing Chan, Lynette LE Oon,
Jenny GH Low, Yvonne CF Su, Linfa
Wang, Gavin JD Smith

32/33

medRxiv preprint doi: https://doi.org/10.1101/2020.02.07.20021139; this version posted February 17, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Table 23. Nucleotide sequences used in this study that were obtained from the GISAID EpiFlu Database™(contd.).
Collection date

Sequence id

Originating lab

Submitting lab

Authors

28/01/20

BetaCoV/Germany/BavPat 1/2020

Charité
Universitaétsmedizin Berlin

Charité
Universitaétsmedizin
Berlin,
Institute of Virology

28/01/20

BetaCoV/Australia/QLD0O1/2020

Pathology Queensland

Public Health Virology
Laboratory

29/01/20

BetaCoV/England/01/2020

Respiratory Virus Unit

Respiratory Virus Unit,
Microbiology
Services
Colindale,
Public
Health England

29/01/20

BetaCoV/England/02/2020

Respiratory Virus Unit

Respiratory Virus Unit,
Microbiology
Services
Colindale,
Public
Health England

29/01/20

BetaCoV/Finland/1/2020

Lapland Central Hospital

29/01/20

BetaCoV/USA/CA3/2020

California
of Health

Department

29/01/20

BetaCoV/USA/CA4/2020

California
of Health

Department

29/01/20

BetaCoV/USA/CA5/2020

California
of Health

Department

29/01/20

BetaCo V/France/IDF05 15/2020

Department
tious
and
Diseases

Department of Virology,
University of Helsinki
and Helsinki University
Hospital, Helsinki, Finland
Pathogen
Discovery,
Respiratory
Viruses
Branch,
Division
of
Viral Diseases, Centers
for Disease Control and
Pathogen
Discovery,
Respiratory
Viruses
Branch,
Division
of
Viral Diseases, Centers
for Dieases Control and
Pathogen
Discovery,
Respiratory
Viruses
Branch,
Division
of
Viral Diseases, Centers
for Dieases Control and
National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris

Victor M Corman, Julia Schneider,
Talitha Veith, Barbara Miihlemann,
Markus Antwerpen, Christian Drosten,
Roman Wolfel
Ben Huang, Alyssa Pyke, Amanda
De Jong, Andrew Van Den Hurk,
Carmel Taylor, David Warrilow, Doris
Genge, Elisabeth Gamez, Glen Hewitson, Ian Maxwell Mackay, Inga Sultana, Jamie McMahon, Jean Barcelon,
Judy Northill, Mitchell Finger, Natalie Simpson, Neelima Nair, Peter Burtonclay, Peter Moore, Sarah
Wheatley, Sean Moody, Sonja HallMendelin, Timothy Gardam, and Frederick Moore.
Monica Galiano, Shahjahan Miah,
Richard
Myers,
Angie
Lackenby,
Omolola
Akinbam1,
Tiina
Talts,
Leena
Bhaw,
Kirstin
Edwards,
Jonathan Hubb, Joanna Ellis, Maria
Zambon
Monica Galiano, Shahjahan Miah,
Richard
Myers,
Angie
Lackenby,
Omolola
Akinbam1,
Tiina
Talts,
Leena
Bhaw,
Kirstin
Edwards,
Jonathan Hubb, Joanna Ellis, Maria
Zambon.
Teemu Smura, Suvi Kuivanen, Hannimari Kallio-Kokko, Olli Vapalahti

29/01/20

BetaCov/France/IDF0626/2020

Sorbonne Université

National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris

30/01/20

BetaCoV/Australia/QLD02/2020

Pathology Queensland

Public Health Virology
Laboratory

31/01/20

BetaCoV/Taiwan/NTU01/2020

Department of Laboratory Medicine

1/02/20

BetaCoV/Singapore/3/2020

National Centre for Infectious Diseases

Microbial
Genomics
Core
Lab,
National
Taiwan University Centers of Genomic and
Precision Medicine
Programme in Emerging Infectious Diseases,
Duke-NUS
Medical
School

3/02/20

BetaCoV/Belgium/GHB-0302 1/2020

KU Leuven

of InfecTropical

KU Leuven,
Clinical
and
Epidemiological
Virology

NA

NA

NA

Mélanie Albert, Marion Barbet, Sylvie
Behillil, Méline Bizard, Angela Brisebarre, Flora Donati, Vincent Enouf,
Maud Vanpeene, Sylvie van der Werf,
Yazdan Yazdanpanah, Xavier Lescure
Mélanie Albert, Marion Barbet, Sylvie
Behillil, Méline Bizard, Angela Brisebarre, Flora Donati, Vincent Enouf,
Maud Vanpeene,
Sylvie van der
Werf, Sonia Burrel, Anne-Genevieve
Marcelin,
Vincent Calvez,
David
Boutolleau, Elise Klément, Valérie
Pourcher, Eric Caumes.
Ben Huang, Alyssa Pyke, Amanda
De Jong, Andrew Van Den Hurk,
Carmel Taylor, David Warrilow, Doris
Genge, Elisabeth Gamez, Glen Hewitson, Ian Maxwell Mackay, Inga Sultana, Jamie McMahon, Jean Barcelon,
Judy Northill, Mitchell Finger, Natalie Simpson, Neelima Nair, Peter Burtonclay, Peter Moore, Sarah
Wheatley, Sean Moody, Sonja HallMendelin, Timothy Gardam, and Frederick Moore.
Shiou-Hwei Yeh, You-Yu Lin, YaYun Lai, Chiao-Ling Li, Shan-Chwen
Chang, Pei-Jer Chen, Sui- Yuan
Chang
Danielle E Anderson, Martin Linster, Yan Zhuang, Jayanthi Jayakumar, David CB Lye, Yee Sin Leo, Barnaby E Young, Yvonne CF Su, Linfa
Wang, Gavin JD Smith
Bert Vanmechelen, Elke Wollants,
Annabel Rector, Els Keyaerts, Lies
Laenen, Marc Van Ranst, and Piet
Maes

33/33

